Securities Registration Statement (s-1)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Bravatek Solutions, Inc.

(Exact name of registrant as specified in its charter)

Colorado

7372

32-0201472

(State of Incorporation)

(Primary Standard Industrial

Classification Number)

(IRS Employer

Identification Number)

2028 E. Ben White Blvd, #240-2835
Austin, TX 78741

(866) 204-6703

(Address, including zip code, and telephone number, including area code,

of registrant's principal executive offices)

Please send copies of all communications to:

BRUNSON CHANDLER & JONES, PLLC

175 South Main Street, Suite 1410

Salt Lake City, UT 84111

801-303-5737

(Address, including zip code, and telephone, including area code)

Approximate date of proposed sale to the public: From time to time after the effective date of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. x

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

If this Form is a post-effective amendment filed pursuant to rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	x
(do not check if a smaller reporting company)		Emerging Growth Company	¨

CALCULATION OF REGISTRATION FEE

Title of Each Class of securities to be registered

Number of shares of

common stock to be registered (1)

Proposed

Maximum

Offering

Price Per

Share (2)

Proposed

Maximum

Aggregate

Offering

Price

Amount of

Registration

Fee (3)

Common Stock

1,000,000,000

0.0007

700,000

84.84

___________

(1)	In accordance with Rule 416(a), this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

(2)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457 under the Securities Act of 1933, as amended. The shares offered, hereunder, may be sold by the selling stockholder from time to time in the open market, through privately negotiated transactions, or a combination of these methods at market prices prevailing at the time of sale or at negotiated prices.

(3)	The fee is calculated by multiplying the aggregate offering amount by 0.0001212, pursuant to Section 6(b) of the Securities Act of 1933.

We hereby amend this registration statement on such date or dates as may be necessary to delay our effective date until the registrant shall file a further amendment which specifically states that this registration statement shall, thereafter, become effective in accordance with Section 8(a) of the Securities Act of 1933, or until the registration statement shall become effective on such date as the Commission, acting pursuant to Section 8(a) may determine.

PROSPECTUS SUBJECT TO COMPLETION DATED October ____, 2018

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

Bravatek Solutions, Inc.

1,000,000,000 Common Shares

The selling stockholder identified in this prospectus may offer an indeterminate number of shares of its common stock, which will consist of up to 1,000,000,000 shares of common stock to be sold by Triton Funds LP (“Triton”) pursuant to an Equity Purchase Agreement (the “Purchase Agreement”) dated May 7, 2018. If issued presently, the 1,000,000,000 shares of common stock registered for resale by Triton would represent approximately 9.1% of our issued and outstanding shares of common stock (based upon us having 9,982,694,590 shares of common stock outstanding as of September 30, 2018 and issuing 1,000,000,000 shares of common stock to Triton).

The selling stockholder may sell all or a portion of the shares being offered pursuant to this prospectus at fixed prices and prevailing market prices at the time of sale, at varying prices, or at negotiated prices.

We will not receive any proceeds from the sale of the shares of our common stock by Triton. However, we will receive proceeds from our initial sale of shares to Triton pursuant to the Purchase Agreement. We will sell shares to Triton at a price equal to 75% of the lowest volume-weighted average price of our common stock during the 5 consecutive trading day period beginning the day after we deliver a Capital Call Notice and shares to Triton.

Triton is an underwriter within the meaning of the Securities Act of 1933, and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act of 1933 in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act of 1933.

Our common stock is quoted on the OTC Link LLC (“OTC Link”) operated by OTC Markets Group Inc. under the symbol “BVTK”. On October 22, 2018, the last reported sale price for our common stock was $0.0007 per share.

Prior to this offering, there has been a limited market for our securities. While our common stock is traded on the OTC Link, trading volume has been very volatile. There is no guarantee that an active trading market will exist for our securities.

This offering is highly speculative, and these securities involve a high degree of risk and should be considered only by persons who can afford the loss of their entire investment. See “Risk Factors” beginning on page 8. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

The date of this prospectus is October __, 2018.

Table of Contents

The following table of contents has been designed to help you find information contained in this prospectus. We encourage you to read the entire prospectus.

Item 3.	Summary Information	5

Item 4.	Use of Proceeds	12

Item 5.	Determination of Offering Price	12

Item 6.	Dilution	12

Item 7.	Selling Security Holder	13

Item 8.	Plan of Distribution	14

Item 9.	Description of Securities to be Registered	15

Item 10.	Interests of Named Experts and Counsel	21

Item 11.	Information with Respect to the Registrant	22

Item 12.	Incorporation of Certain Information by Reference.

Item 13.	Other Expenses of Issuance and Distribution	43

Item 14.	Indemnification of Officers and Directors	43

Item 15.	Recent Sales of Unregistered Securities	43

Item 16.	Exhibits and Financial Statement Schedules.	64

Item 17.	Undertakings.	65

Financial Statements		F-1

We have not authorized any person to give you any supplemental information or to make any representations for us. You should not rely upon any information about our company that is not contained in this prospectus. Information contained in this prospectus may become stale. You should not assume the information contained in this prospectus or any prospectus supplement is accurate as of any date other than their respective dates, regardless of the time of delivery of this prospectus, any prospectus supplement or of any sale of the shares. Our business, financial condition, results of operations, and prospects may have changed since those dates. The selling stockholders are offering to sell and seeking offers to buy shares of our common stock only in jurisdictions where offers and sales are permitted.

In this prospectus, the “Company,” “Bravatek,” “Bravatek Solutions,” “we,” “us,” and “our,” refer to Bravatek Solutions, Inc., a Colorado corporation.

Item 3. SUMMARY INFORMATION

You should carefully read all information in the prospectus, including the financial statements and their explanatory notes under the Financial Statements prior to making an investment decision.

Bravatek Solutions, Inc., a Colorado corporation, was incorporated in the State of Colorado, on April 19, 2007. The Company provides security, defense, and information security solutions, which assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructures against error, and physical and cyber-attack. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services, including telecom services. Products include software, hardware and services, and span a variety of industries including, but not limited to, email security, user authentication, telecommunications and cyber breach protection.

The Company has developed and plans to continue selling an enterprise-level secure email software appliance named Ecrypt One. Ecrypt One is a patent-pending email server with integrated security technology. It was designed to protect email and attachments in transit and at rest. It incorporates multiple security technologies and techniques, such as encryption, role-based access controls, server rules that enforce security, and multi-factor authentication. It was designed to assist organizations and governments to meet and maintain compliance with information security regulations such as HIPAA. The Company has filed patent applications for multiple attributes and processes contained in Ecrypt One. Additionally, the Company began taking pre-orders of Tuitio, a consumer software cybersecurity product (protected by two issued patents), in the second quarter of 2018.

The Company acquired HelpComm, Inc., a Virginia corporation engaged in providing telecom services, during the first quarter of 2018, and the consolidated results of operations described elsewhere herein for the three and six months ended June 30, 2018, include the results of HelpComm and the Company, while the results of operations for the three and six months ended June 30, 2017, are only for the Company.

Our independent public accounting firm has issued an audit opinion, which includes a statement that the results of our operations and our financial condition raise substantial doubt about our ability to continue as a going concern.

About this Offering

This prospectus relates to the resale of up to 1,000,000,000 shares of our common stock issuable to Triton Funds LP, a Delaware limited partnership (“Triton”), pursuant to an Equity Purchase Agreement with us dated May 7, 2018, which was amended on August 31, 2018 (the “Purchase Agreement”),

Pursuant to the Purchase Agreement as amended, we have the right to “put” to Triton (the “Put Right”) up to $1 million in shares of our common stock (i.e., we can compel Triton to purchase our common stock at a pre-determined formula) during a term through June 30, 2019, unless sooner terminated. Accordingly, this prospectus relates to the resale of up to 1,000,000,000 shares of our common stock by Triton.

For the purpose of determining the number of shares of common stock to be offered pursuant to this prospectus, we have assumed that we will issue not more than 1,000,000,000 shares pursuant to the exercise of the Put Right, although the number of shares that we will actually issue pursuant to the Put Right could be more or less than 1,000,000,000, depending on the trading price of our common stock. We do not currently intend to exercise the Put Right in a manner which would result in our issuance of more than 1,000,000,000 shares, but if we were to exercise the Put Right in that manner, we would be required to file a subsequent registration statement with the Securities and Exchange Commission (“SEC”), and that registration statement would have to be declared effective prior to our issuance of any additional shares to Triton.

During the term of the Purchase Agreement, we have the right to deliver a capital call notice (“Capital Call Notice”) to Triton requiring it to purchase a number of shares of our common stock for a specific amount (the “Investment Amount”). We will deliver to Triton with each Capital Call Notice a number of shares of our common stock (“Capital Call Shares”). The purchase price for Capital Call Shares covered by a Capital Call Notice will be equal to 75% of the lowest volume-weighted average price of our common stock during the 5 consecutive trading day period beginning the day after we deliver a Capital Call Notice to Triton and Triton receives the Capital Call Shares (such purchase price a “Purchase Price” and such date that Triton receives Capital Call Shares a “Clearing Date”). Triton will then deliver to the Company the Purchase Price for a Capital Call Notice 6 trading days after each Clearing Date.

Table of Contents

The number of shares sold to Triton at any time will not exceed the number of shares that, when aggregated with all other shares of our common stock then beneficially owned by Triton, would result in Triton owning more than 4.99% of our outstanding common stock.

Triton has indicated that it will resell our shares it purchases pursuant to the Purchase Agreement in the open market, resell our shares to other investors through negotiated transactions, or hold our shares in its portfolio. This prospectus covers, in part, the resale of our stock by Triton either in the open market or to other investors through negotiated transactions. Triton’s obligations under the Purchase Agreement are not assignable.

All equity offerings are dilutive except that in this case we control the dilution. The increase in the number of our shares for sale resulting from our exercise of a Put Right pursuant to the Purchase Agreement will likely decrease the prevailing market price per share of our stock and also result in a reduction in the ownership percentage of our company for present stockholders. Other than as set forth below, there are no limits on our ability to put stock to Triton pursuant to the Purchase Agreement, except for the prohibition on Triton owning more than 4.99%, and that the equity line of credit expires on June 30, 2019, or after $1,000,000 in stock has been sold to Triton.

Triton will only purchase shares when we meet the following conditions:

·	A registration statement has been declared effective and remains effective for the resale of the common stock subject to the Purchase Agreement;
·	Our common stock has not been suspended from trading, our common stock is approved for listing or quotation on the OTC Link and is eligible at the Depository Trust Company (“DTC”) for full services including DTC’s DWAC system;
·	We have complied with our obligations under the Purchase Agreement;
·	No injunction, rule, statute, order, or ruling has been entered or adopted that prohibits or materially adversely the purchase or the issuance of our common stock; and we have not filed a petition in bankruptcy, either voluntarily or involuntarily, and there shall not have been commenced any proceedings under any bankruptcy or insolvency laws;
·	Since the filing of our most recent SEC report, no event has occurred (1) which has any effect on our business, operations, properties, or financial condition that is material and adverse to us, or (2) that would prohibit or otherwise materially interfere with our ability perform our obligations under the Purchase Agreement; and
·	The Company has no knowledge of any event more likely than not to cause the registrations statement to be suspended or otherwise ineffective.

The Purchase Agreement will terminate when the following events occur:

·	Triton has purchased an aggregate of $1,000,000 of our common stock;
·	June 30, 2019 has passed; or
·	The Company notifies Triton in writing of termination of the Purchase Agreement upon a material breach of the Purchase Agreement by Triton.

As we draw down on the Purchase Agreement, shares of our common stock will be sold into the market by Triton. The sale of these additional shares could cause our stock price to decline. In turn, if the stock price declines, and we issue more Capital Call Notices, more shares will come into the market, which could cause a further drop in our stock price. You should be aware that there is an inverse relationship between the market price of our common stock and the number of shares to be issued under the Purchase Agreement. If our stock price declines, we will be required to issue a greater number of shares under the Purchase Agreement for any given targeted Investment Amount.

We have no obligation to utilize the full amount available under the Purchase Agreement.

Fees Paid to Triton

There are no fees payable to Triton in this transaction.

Table of Contents

The Offering

Shares of common stock offered by Triton:	Up to 1,000,000,000 shares of common stock, which would represent approximately 9.1% of our outstanding common stock. ¹
Common stock to be outstanding after the offering:	Up to 10,982,694,590 shares of common stock. ¹
Use of proceeds:	We will not receive any proceeds from the sale of the shares by Triton. However, we will receive proceeds from sale of shares to Triton pursuant to the Purchase Agreement. See “Use of Proceeds.”
Risk factors:	You should carefully read and consider the information set forth under the caption “Risk Factors” beginning on page 8 and all other information set forth in this prospectus before investing in our common stock.
OTC Markets (OTC Link) Symbol:	BVTK

___________

¹ Assuming 1,000,000,000 shares are issued to Triton, and immediately prior to the issuance, 9,982,694,590 shares of common stock are outstanding (which is the number of shares of our common stock outstanding as of September 30, 2018).

Negative Impact and Limits on Equity Line of Credit

The resale of shares by Triton will have a dilutive effect upon existing shareholders. Further, by causing up to 1,000,000,000 shares of common stock to be ingested into the current market, there could be increased difficulty in liquidating existing ownership positions in our shares of common stock. If Triton does not purchase any shares put to it, we will not receive any funds from this offering. Triton must purchase all of the shares of common stock we put to it pursuant to the Purchase Agreement, provided that Triton does not own more than 4.99% of our total outstanding shares of common stock. Further, we will not be entitled to deliver a Capital Call Notice to Triton, and Triton will not be obligated to purchase any shares unless the following conditions are satisfied:

·	A registration statement has been declared effective and remains effective for the resale of the common stock subject to the Purchase Agreement;
·	Our common stock has not been suspended from trading, our common stock is approved for listing or quotation on the OTC Link and is eligible at the Depository Trust Company (“DTC”) for full services including DTC’s DWAC system;
·	We have complied with our obligations under the Purchase Agreement;
·	No injunction, rule, statute, order, or ruling has been entered or adopted that prohibits or materially adversely the purchase or the issuance of our common stock; and we have not filed a petition in bankruptcy, either voluntarily or involuntarily, and there shall not have been commenced any proceedings under any bankruptcy or insolvency laws;
·	Since the filing of our most recent SEC report, no event has occurred (1) which has any effect on our business, operations, properties, or financial condition that is material and adverse to us, or (2) that would prohibit or otherwise materially interfere with our ability perform our obligations under the Purchase Agreement; and
·	The Company has no knowledge of any event more likely than not to cause the registrations statement to be suspended or otherwise ineffective.

If each of the above conditions is not satisfied, Triton will have no obligation to purchase shares put to it.

As of October 22, 2018, the closing market price for our shares of common stock was $0.0007 per share. Based on that price, we could put all 1,000,000,000 shares of common stock to Triton, and we would receive $0.000525 per share or a total of $525,000. It is unlikely that we will ever receive the full $1,000,000 available under the Purchase Agreement.

Past Transactions with Triton Funds LP

We have not entered into or completed any transactions with Triton. On May 8, 2018, the Company determined to donate 25,000,000 shares of the Company’s common stock to Triton Funds LLC, an affiliate of Triton.

Special Information Regarding Forward-Looking Statements

Some of the statements in this prospectus are “forward-looking statements.” These forward-looking statements involve certain known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These factors include, among others, the factors set forth herein under “Risk Factors.” The words “believe,” “expect,” “anticipate,” “intend,” “plan,” “may,” “could,” “hope,” and similar expressions identify forward-looking statements. We caution you not to place undue reliance on these forward-looking statements. We undertake no obligation to update and revise any forward-looking statements or to publicly announce the result of any revisions to any of the forward-looking statements in this document to reflect any future or developments. However, the Private Securities Litigation Reform Act of 1995 is not available to us as a non- reporting issuer. Further, Section 27A(b)(2)(D) of the Securities Act and Section 21E(b)(2)(D) of the Securities Exchange Act expressly state that the safe harbor for forward looking statements does not apply to statements made in connection with an initial public offering.

Table of Contents

RISK FACTORS

An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this report, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment. You should read the section entitled “Special Information Regarding Forward-Looking Statements” above for a discussion of what types of statements are forward-looking statements, as well as the significance of such statements in the context of this report.

You should carefully consider the risks described below together with all of the other information included in this report before making an investment decision with regard to our securities. The statements contained in or incorporated into this prospectus that are not historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. If any of the following risks actually occur, our business, financial condition or results of operations could be harmed. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment.

Risks Related to Our Business

There is doubt about our ability to continue as a going concern due to our operating history of net losses, negative working capital and insufficient cash flows, and lack of liquidity to pay our current obligations, all of which means that we may not be able to continue operations.

Our independent auditors have added an explanatory paragraph to their audit opinion issued in connection with our financial statements for the nine months ended December 31, 2017, and the year ended March 31, 2017, with respect to their doubt about our ability to continue as a going concern. The fact that we have generally had net losses after consideration of income taxes, that we had negative working capital and insufficient cash flows from operation as of June 30, 2018, and do not have the requisite liquidity to pay our current obligations, raise substantial doubt about our ability to continue as a going concern for a reasonable period of time.

We sell our products and services in highly competitive markets, which results in pressure on our profit margins and limits our ability to maintain or increase the market share of our services.

The software and telecom industries are subject to significant competition and pricing pressures. We experience significant competitive pricing pressures as well as competitive products. Several significant competitors offer products and services with prices that match or are lower than ours. We believe that the products and services we offer are generally competitive with those offered by other software and telecom companies. It is possible that one or more of our competitors could develop a significant advantage over us that allows them to provide superior products or pricing, which could put us at a competitive disadvantage. Continued pricing pressure or improvements in research and shifts in customer preferences away from natural supplements could adversely impact our customer base or pricing structure and have a material and adverse effect on our business, financial condition, results of operations and cash flows.

Our future growth is largely dependent upon our ability to successfully compete with new and existing competitors by developing or acquiring new products that achieve market acceptance with acceptable margins.

Our business operates in technology markets that are characterized by rapidly changing products, evolving industry standards and potential new entrants. For example, a number of new companies with innovative software products that promise significant cybersecurity advantages are established every year and are competitive with our products. If these companies gain market acceptance, our ability to grow our business could be materially and adversely affected. Accordingly, our future success depends upon a number of factors, including our ability to accomplish the following: identify emerging technology, software and telecom trends in our target end-markets; develop, acquire and maintain competitive products and services; enhance our products and services by adding innovative features that differentiate us from our competitors; and develop or acquire and bring products and services to market quickly and cost-effectively. Our ability to develop or acquire new products based on quality research can affect our competitive position and requires the investment of significant resources. These acquisitions and development efforts divert resources from other potential investments in our businesses, and they may not lead to the development of new research or products on a timely basis. New or enhanced products may not satisfy consumer preferences and potential product failures may cause consumers to reject these products. As a result, these products may not achieve market acceptance and our brand image could suffer. In addition, our competitors may introduce superior designs or business strategies, impairing our brand and the desirability of our products, which may cause consumers to defer or forego purchases of our products. Also, the markets for our products and services may not develop or grow as we anticipate. The failure of our products to gain market acceptance, the potential for product defects or the obsolescence of our products could significantly reduce our revenue, increase our operating costs or otherwise adversely affect our business, financial condition, results of operations or cash flows.

We rely on highly skilled personnel, and if we are unable to retain or motivate key personnel or hire qualified personnel, we may not be able to grow effectively.

Our performance largely depends on the talents and efforts of highly skilled individuals. Our future success depends on our continuing ability to identify, hire, develop, motivate and retain highly skilled personnel for all areas of our organization, particularly sales and marketing. Competition in our industry for qualified employees is intense. In addition, our compensation arrangements, such as our bonus programs, may not always be successful in attracting new employees or retaining and motivating our existing employees. Our continued ability to compete effectively depends on our ability to attract new employees and to retain and motivate our existing employees.

Table of Contents

Our operating results may fluctuate, which makes our results difficult to predict and could cause our results to fall short of expectations.

Our operating results may fluctuate as a result of a number of factors, many of which may be outside of our control. As a result, comparing our operating results on a period-to-period basis may not be meaningful, and you should not rely on our past results as an indication of our future performance. Our quarterly, year-to-date, and annual expenses as a percentage of our revenues may differ significantly from our historical or projected rates. Our operating results in future quarters may fall below expectations. Each of the following factors may affect our operating results:

	·	our ability to deliver products and services in a timely manner in sufficient volumes;
	·	our ability to recognize technology trends;
	·	our loss of one or more significant customers;
	·	the introduction of successful new products by our competitors; and
	·	adverse media reports on our software products and telecom services.

Because our business is changing and evolving, our historical operating results may not be useful to you in predicting our future operating results.

We may not be able to secure additional financing to meet our future capital needs due to changes in general economic conditions.

We anticipate needing significant capital to fulfill our contractual obligations and execute our business plan generally. We may use capital more rapidly than currently anticipated and incur higher operating expenses than currently expected, and we may be required to depend on external financing to satisfy our operating and capital needs. We may need new or additional financing in the future to conduct our operations or expand our business. Any sustained weakness in the general economic conditions and/or financial markets in the United States or globally could adversely affect our ability to raise capital on favorable terms or at all. From time to time we have relied, and may also rely in the future, on access to financial markets as a source of liquidity to satisfy working capital requirements and for general corporate purposes. We may be unable to secure debt or equity financing on terms acceptable to us, or at all, at the time when we need such funding. If we do raise funds by issuing additional equity or convertible debt securities, the ownership percentages of existing stockholders would be reduced, and the securities that we issue may have rights, preferences or privileges senior to those of the holders of our common stock or may be issued at a discount to the market price of our common stock which would result in dilution to our existing stockholders. If we raise additional funds by issuing debt, we may be subject to debt covenants, which could place limitations on our operations including our ability to declare and pay dividends. Our inability to raise additional funds on a timely basis would make it difficult for us to achieve our business objectives and would have a negative impact on our business, financial condition and results of operations.

Our business and operating results could be harmed if we fail to manage our growth or change.

Our business may experience periods of rapid change and/or growth that could place significant demands on our personnel and financial resources. To manage possible growth and change, we must continue to try to locate skilled employees and professionals and adequate funds in a timely manner.

Our business strategy includes making acquisitions and investments that complement our existing business. These acquisitions and investments could be unsuccessful or consume significant resources, which could adversely affect our operating results.

We will continue to analyze and evaluate the acquisition of strategic businesses or product lines with the potential to strengthen our industry position or enhance our existing set of products and service offerings. We cannot assure you that we will identify or successfully complete transactions with suitable acquisition candidates in the future, nor can we assure you that completed acquisitions will be successful.

Acquisitions and investments may involve significant expenditures, debt incurrence, operating losses and expenses that could have a material adverse effect on our business, financial condition, results of operations and cash flows. Acquisitions involve numerous other risks, including:

	·	diversion of management time and attention from daily operations;
	·	difficulties integrating acquired businesses, technologies and personnel into our business;
	·	difficulties in obtaining and verifying the financial statements and other business information of acquired businesses;
	·	inability to obtain required regulatory approvals and/or required financing on favorable terms;
	·	potential loss of key employees, key contractual relationships or key customers of acquired companies or of us;
	·	assumption of the liabilities and exposure to unforeseen liabilities of acquired companies; and
	·	dilution of interests of holders of shares of our common stock through the issuance of equity securities or equity-linked securities.

It may be difficult for us to complete transactions quickly and to integrate acquired operations efficiently into our current business operations. Any acquisitions or investments may ultimately harm our business or financial condition, as such acquisitions may not be successful and may ultimately result in impairment charges.

Table of Contents

Our insurance coverage or third-party indemnification rights may not be sufficient to cover our legal claims or other losses that we may incur in the future.

We maintain insurance, including property, general and product liability, and workers’ compensation to protect ourselves against potential loss exposures. In the future, insurance coverage may not be available at adequate levels or on adequate terms to cover potential losses, including on terms that meet our customer’s requirements. If insurance coverage is inadequate or unavailable, we may face claims that exceed coverage limits or that are not covered, which could increase our costs and adversely affect our operating results.

Our intellectual property rights are valuable, and any inability to protect them could reduce the value of our products and brand.

We have invested significant resources to protect our intellectual property rights. However, we may be unable or unwilling to strictly enforce our intellectual property rights from infringement. Our failure to enforce our intellectual property rights could diminish the value of our brands and product offerings and harm our business and future growth prospects.

We may be subject to intellectual property rights claims, which are costly to defend, could require us to pay damages and could limit our ability to sell some of our products.

Our industry is characterized by vigorous pursuit and protection of intellectual property rights, which has resulted in protracted and expensive litigation for several companies. Third parties may assert claims of misappropriation of trade secrets or infringement of intellectual property rights against us or against our end customers or partners for which we may be liable.

As our business expands, the number of products and competitors in our markets increases and product overlaps occur, infringement claims may increase in number and significance. Intellectual property lawsuits are subject to inherent uncertainties due to the complexity of the technical issues involved, and we cannot be certain that we would be successful in defending ourselves against intellectual property claims. Further, many potential litigants have the capability to dedicate substantially greater resources than we can to enforce their intellectual property rights and to defend claims that may be brought against them. Furthermore, a successful claimant could secure a judgment that requires us to pay substantial damages or prevents us from distributing products or performing certain services.

Risks Relating to Ownership of Our Securities

Our stock price may be volatile, which may result in losses to our shareholders.

The stock markets have experienced significant price and trading volume fluctuations, and the market prices of companies listed on the over-the-counter markets in which shares of our common stock are quoted for trading have been volatile in the past and have experienced sharp share price and trading volume changes. The trading price of our common stock is likely to be volatile and could fluctuate widely in response to many factors, including the following, some of which are beyond our control:

	o	variations in our operating results;
	o	changes in expectations of our future financial performance, including financial estimates by securities analysts and investors;
	o	changes in operating and stock price performance of other companies in our industry;
	o	additions or departures of key personnel; and
	o	future sales of our common stock.

Domestic and international stock markets often experience significant price and volume fluctuations. These fluctuations, as well as general economic and political conditions unrelated to our performance, may adversely affect the price of our common stock.

Our common shares may become thinly traded and you may be unable to sell at or near ask prices, or at all.

We cannot predict the extent to which an active public market for trading our common stock will be sustained.

This situation is attributable to a number of factors, including the fact that we are a small company which is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community who generate or influence sales volume. Even if we came to the attention of such persons, those persons tend to be risk-averse and may be reluctant to follow, purchase, or recommend the purchase of shares of an unproven company such as ours until such time as we become more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market for our common stock will develop or be sustained, or that current trading levels will be sustained.

The market price for our common stock is particularly volatile given our status as a relatively small company, which could lead to wide fluctuations in our share price. You may be unable to sell your common stock at or above your purchase price if at all, which may result in substantial losses to you.

Table of Contents

Shareholders should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. The occurrence of these patterns or practices could increase the volatility of our share price.

We do not anticipate paying any cash dividends to our common shareholders.

We presently do not anticipate that we will pay dividends on any of our common stock in the foreseeable future. If payment of dividends does occur at some point in the future, it would be contingent upon our revenues and earnings, if any, capital requirements, and general financial condition. The payment of any common stock dividends will be within the discretion of our Board of Directors. We presently intend to deploy available capital to execute our business plan; accordingly, we do not anticipate the declaration of any dividends for common stock in the foreseeable future.

Because the SEC imposes additional sales practice requirements on brokers who deal in shares of penny stocks, some brokers may be unwilling to trade our securities. This means that you may have difficulty reselling your shares, which may cause the value of your investment to decline.

Our shares are classified as penny stocks and are covered by Section 15(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) which imposes additional sales practice requirements on brokers-dealers who sell our securities in this offering or in the aftermarket. For sales of our securities, broker-dealers must make a special suitability determination and receive a written agreement from you prior to making a sale on your behalf. Because of the imposition of the foregoing additional sales practices, it is possible that broker-dealers will not want to make a market in our common stock. This could prevent you from reselling your shares and may cause the value of your investment to decline.

Financial Industry Regulatory Authority (FINRA) sales practice requirements may limit your ability to buy and sell our common stock, which could depress the price of our shares.

FINRA rules require broker-dealers to have reasonable grounds for believing that an investment is suitable for a customer before recommending that investment to the customer. Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status and investment objectives, among other things. Under interpretations of these rules, FINRA believes that there is a high probability such speculative low-priced securities will not be suitable for at least some customers. Thus, FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our shares, have an adverse effect on the market for our shares, and thereby depress our share price.

Volatility in our common share price may subject us to securities litigation.

The market for our common stock is characterized by significant price volatility as compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. In the past, plaintiffs have initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may, in the future, be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and could divert management's attention and resources.

The elimination of monetary liability against our directors, officers and employees under Colorado law and the existence of indemnification rights of our directors, officers and employees may result in substantial expenditures by our Company and may discourage lawsuits against our director, officer and employees.

Our articles of incorporation provide that directors and officers of the Company will be indemnified to the broadest extent as permitted by Colorado law. We may also have contractual indemnification obligations under our employment agreements with our officers. The foregoing indemnification obligations could result in our company incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may be unable to recoup. These provisions and resultant costs may also discourage our company from bringing a lawsuit against directors and officers for breaches of their fiduciary duties and may similarly discourage the filing of derivative litigation by our shareholders against our directors and officers even though such actions, if successful, might otherwise benefit our company and shareholders.

Table of Contents

Our business is subject to changing regulations related to corporate governance and public disclosure that have increased both our costs and the risk of noncompliance.

Because our common stock is publicly traded, we are subject to certain rules and regulations of federal, state and financial market exchange entities charged with the protection of investors and the oversight of companies whose securities are publicly traded. These entities, including the Public Company Accounting Oversight Board, the SEC and FINRA, have issued requirements and regulations and continue to develop additional regulations and requirements in response to corporate scandals and laws enacted by Congress, most notably the Sarbanes-Oxley Act of 2002. Our efforts to comply with these regulations have resulted in, and are likely to continue resulting in, increased general and administrative expenses and diversion of management time and attention from revenue-generating activities to compliance activities. Because new and modified laws, regulations and standards are subject to varying interpretations in many cases due to their lack of specificity, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices.

Our outstanding securities may become freely tradable pursuant to Rule 144 and may dilute the market for your shares and have a depressive effect on the price of the shares of our common stock.

We have outstanding a large number of shares of preferred stock and convertible promissory notes convertible into the Company’s common stock. Many of these securities could currently be characterized as “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”) (“Rule 144”). As restricted securities, these securities may be converted into common stock that can be resold only pursuant to an effective registration statement or under the requirements of Rule 144 or other applicable exemptions from registration under the Securities Act and as required under applicable state securities laws. Rule 144 provides in essence that once restricted securities have been held for a period of at least six months and the other requirements in the rule have been satisfied, holders of the securities may resell their securities without registration or restriction on transfer. As many of our outstanding convertible securities have been held by the holders in excess of six months, such holders may be able to convert such securities into common stock and sell the common stock into the market. Such conversion would be dilutive to existing common shareholders, and such sales would likely have a depressive effect upon our stock price.

Our existing stockholders may experience significant dilution from the sale of our common stock pursuant to the Triton Purchase Agreement.

The sale of our common stock to Triton in accordance with the Purchase Agreement will have a dilutive impact on our shareholders. As a result, the market price of our common stock could decline. In addition, the lower our stock price is at the time we exercise our put rights pursuant to the Purchase Agreement, the more shares of our common stock we will have to issue to Triton in order to exercise a put for the same investment amount under the Purchase Agreement. If our stock price decreases, then our existing shareholders would experience greater dilution for any given dollar amount raised through the offering.

The perceived risk of dilution may cause our stockholders to sell their shares, which may cause a decline in the price of our common stock. Moreover, the perceived risk of dilution and the resulting downward pressure on our stock price could encourage investors to engage in short sales of our common stock. By increasing the number of shares offered for sale, material amounts of short selling could further contribute to progressive price declines in our common stock.

Triton will pay less than the then-prevailing market price of our common stock, which could cause the price of our common stock to decline.

Our common stock to be issued under the Triton Purchase Agreement will be purchased by Triton at a price equal to 75% of the lowest volume-weighted average price during the 5 trading days immediately following delivery of our notice to Triton of our election to exercise our "put" right. Triton has a financial incentive to sell our shares immediately upon receiving them to realize the profit between the discounted price and the prevailing market price. If Triton sells our shares, the price of our common stock may decrease. If our stock price decreases, Triton may have further incentive to sell additional shares. Accordingly, the discounted sales price in the Purchase Agreement may cause the price of our common stock to decline.

W e may not have access to the full amount under the Purchase Agreement.

The closing traded price of our common stock immediately on October 22, 2018, was approximately $0.0007. At that price, we would be able to sell shares to Triton under the Purchase Agreement at the discounted price of $0.000525. At that discounted price, the 1,000,000,000 shares would only represent $525,000, which is below Triton’s full commitment amount pursuant to the Purchase Agreement.

Item 4. USE OF PROCEEDS

The Company will use the proceeds from the sale of the Shares for general corporate and working capital purposes and acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in good faith deem to be in the best interest of the Company.

Item 5. DETERMINATION OF OFFERING PRICE

We have not set an offering price for the shares registered hereunder, as the only shares being registered are those sold pursuant to the Triton Purchase Agreement. Triton may sell all or a portion of the shares being offered pursuant to this prospectus at fixed prices and prevailing market prices at the time of sale, at varying prices or at negotiated prices.

Item 6. DILUTION

Not applicable. The shares registered under this registration statement are not being offered for purchase. The shares are being registered on behalf of our selling shareholder pursuant to the Triton Purchase Agreement.

Table of Contents

Item 7. SELLING SECURITY HOLDER

The selling stockholder identified in this prospectus may offer and sell up to 1,000,000,000 shares of our common stock, which consists of shares of common stock to be sold by Triton pursuant to the Purchase Agreement. If issued presently, the shares of common stock registered for resale by Triton would represent approximately 9.1% of our issued and outstanding shares of common stock (based upon us having 9,982,694,590 shares of common stock outstanding as of September 30, 2018 and issuing 1,000,000,000 shares of common stock to Triton).

We may require the selling stockholder to suspend the sales of the shares of our common stock being offered pursuant to this prospectus upon the occurrence of any event that makes any statement in this prospectus or the related registration statement untrue in any material respect or that requires the changing of statements in those documents in order to make statements in those documents not misleading.

The selling stockholder identified in the table below may from time to time offer and sell under this prospectus any or all of the shares of common stock described under the column “Shares of Common Stock Being Offered” in the table below.

Triton will be deemed to be an underwriter within the meaning of the Securities Act. Any profits realized by such selling stockholder may be deemed to be underwriting commissions.

Information concerning the selling stockholder may change from time to time and, if necessary, we will amend or supplement this prospectus accordingly. We cannot give an estimate as to the number of shares of common stock that will actually be held by the selling stockholder upon termination of this offering, because the selling stockholders may offer some or all of the common stock under the offering contemplated by this prospectus or acquire additional shares of common stock. The total number of shares that may be sold, hereunder, will not exceed the number of shares offered, hereby. Please read the section entitled “Plan of Distribution” in this prospectus.

The manner in which the selling stockholder acquired or will acquire shares of our common stock is discussed below under “The Offering.”

The following table sets forth the name of each selling stockholder, the number of shares of our common stock beneficially owned by such stockholder before this offering, the number of shares to be offered for such stockholder’s account and the number and (if one percent or more) the percentage of the class to be beneficially owned by such stockholder after completion of the offering. The number of shares owned are those beneficially owned, as determined under the rules of the SEC, and such information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares of our common stock as to which a person has sole or shared voting power or investment power and any shares of common stock which the person has the right to acquire within 60 days, through the exercise of any option, warrant or right, through conversion of any security or pursuant to the automatic termination of a power of attorney or revocation of a trust, discretionary account or similar arrangement, and such shares are deemed to be beneficially owned and outstanding for computing the share ownership and percentage of the person holding such options, warrants or other rights, but are not deemed outstanding for computing the percentage of any other person. Beneficial ownership percentages are calculated based on having 9,982,694,590 shares of common stock outstanding as of September 30, 2018.

Unless otherwise set forth below, (a) the persons and entities named in the table have sole voting and sole investment power with respect to the shares set forth opposite the selling stockholder’s name, subject to community property laws, where applicable, and (b) no selling stockholder had any position, office or other material relationship within the past three years, with us or with any of our predecessors or affiliates. The number of shares of common stock shown as beneficially owned before the offering is based on information furnished to us or otherwise based on information available to us at the timing of the filing of the registration statement of which this prospectus forms a part.

	Shares Owned by the Selling Stockholders		Shares of Common Stock			Number of Shares to be Owned by Selling Stockholder After the Offering and Percent of Total Issued and Outstanding Shares
Name of Selling Stockholder	before the Offering (1)		Being Offered			# of Shares (2)		% of Class (2)

Triton Funds LP (3)		0		1,000,000,000(	4)		0		0	%

Notes:

(1)	Beneficial ownership is determined in accordance with Securities and Exchange Commission rules and generally includes voting or investment power with respect to shares of common stock. Shares of common stock subject to options, warrants and convertible debentures currently exercisable or convertible, or exercisable or convertible within 60 days, are counted as outstanding. The actual number of shares of common stock issuable upon the conversion of the convertible debentures is subject to adjustment depending on, among other factors, the future market price of our common stock, and could be materially less or more than the number estimated in the table.

(2)	Because the selling stockholder may offer and sell all or only some portion of the 1,000,000,000 shares of our common stock being offered pursuant to this prospectus and may acquire additional shares of our common stock in the future, we can only estimate the number and percentage of shares of our common stock that the selling stockholder will hold upon termination of the offering.

(3)	Upon information and belief, Sam Yaffa exercises voting and dispositive power with respect to the shares of our common stock that are beneficially owned by Triton Funds LP.

(4)	Consists of up to 1,000,000,000 shares of common stock to be sold by Triton pursuant to the Purchase Agreement.

Table of Contents

Item 8. PLAN OF DISTRIBUTION

The selling stockholder named above and any of its successors-in-interest (collectively the “selling stockholders”) may, from time to time, sell any or all of their shares of common stock on OTC Markets or any other stock exchange, market or trading facility on which the shares of our common stock are traded or in private transactions. These sales may be at fixed prices and prevailing market prices at the time of sale, at varying prices or at negotiated prices. The selling stockholders may use any one or more of the following methods when selling shares:

	·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;
	·	block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;
	·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;
	·	privately negotiated transactions;
	·	broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;
	·	a combination of any such methods of sale; or



Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

Triton is an underwriter within the meaning of the Securities Act of 1933 and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act of 1933 in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act of 1933. Triton has informed us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the common stock of our company. Pursuant to a requirement by FINRA, the maximum commission or discount to be received by any FINRA member or independent broker-dealer may not be greater than 8% of the gross proceeds received by us for the sale of any securities being registered pursuant to Rule 415 promulgated under the Securities Act of 1933.

Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by the selling stockholder. The selling stockholder may agree to indemnify any agent, dealer, or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act of 1933.

We are required to pay certain fees and expenses incurred by us incident to the registration of the shares covered by this prospectus. We have agreed to indemnify the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act of 1933. We will not receive any proceeds from the resale of any of the shares of our common stock by the selling stockholders. We may, however, receive proceeds from the sale of our common stock under the Purchase Agreement with Triton. Neither the Purchase Agreement with Triton nor any rights of the parties under the Purchase Agreement with Triton may be assigned or delegated to any other person.

We have entered into an agreement with Triton to keep this prospectus effective until Triton has sold all of the common shares purchased by it under the Purchase Agreement and has no right to acquire any additional shares of common stock under the Purchase Agreement.

The resale shares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the Securities Exchange Act of 1934, any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Securities Exchange Act of 1934 and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholders or any other person. We will make copies of this prospectus available to the selling stockholders.

Table of Contents

Item 9. DESCRIPTION OF SECURITIES TO BE REGISTERED

General

On October 26, 2018, we filed Articles of Amendment to increase the number of shares of common stock we are authorized to issue to 11,600,000,000. As of September 30, 2018, we had 9,982,694,590 shares of common stock outstanding.

Each share of common stock shall have one (1) vote per share. Our common stock does not provide a preemptive, subscription or conversion rights, and there are no redemption or sinking fund provisions or rights. Our common stock holders are not entitled to cumulative voting for election of members of the Board of Directors.

Dividends

We have not paid any dividends on our common stock since our inception and do not intend to pay any dividends in the foreseeable future.

The declaration of any future cash dividends is at the discretion of our board of directors and depends upon our earnings, if any, our capital requirements and financial position, our general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

Options

The following table summarizes stock option information as of September 30, 2018:

Exercise Prices		Outstanding		Weighted Average Contractual Life	Exercisable
$	7,500		12	3.63 Years		12
$	250		90	7.10 Years		90
Total			102	6.69 Years		102

Warrants

The following table summarizes outstanding warrants of the Company as of September 30, 2018:

		Number of Warrants				Weighted-Average Exercise Price per Share				Weighted-Average Remaining Life (Years)
Outstanding and exercisable at September 30, 2018			3,263			$	447				1.99

Table of Contents

Preferred Stock

10,000,000 shares of preferred stock, $0.0001 par value, have been authorized.

Series A Convertible Preferred Stock .

5,000,000 shares of preferred stock are designated as Series A Convertible Preferred Stock (“Series A Preferred Stock”). Each share of Series A Convertible Preferred Stock is convertible at the election of the holder into 0.004 shares of common stock, subject to a 4.9% beneficial ownership limitation, but has no voting rights until converted into common stock. In the event of any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, the holders of the outstanding shares of Series A Convertible Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to its shareholders, whether from capital, surplus funds or earnings, and before any payment is made in respect of the shares of Common Stock, an amount equal to $2.50 per share of Series A Convertible Preferred Stock, subject to adjustment for stock dividends, combinations, splits, recapitalizations and the like with respect to the Series A Convertible Preferred Stock, plus any and all accrued but unpaid dividends. The holders of Series A Convertible Preferred Stock are entitled to dividends when declared by the board of directors. As of September, 30, 2018, there are no shares of Series A Preferred Stock outstanding.

Series B Preferred Stock

350,000 shares of preferred stock are designated as Series B Preferred Stock. Each share of Series B Preferred Stock is convertible at the election of the holder into .004 shares of common stock, subject to a 4.9% beneficial ownership limitation. Series B Preferred Stock has no voting rights until converted into common stock. The holders of the Series B Preferred Stock do not have any rights to dividends or any liquidation preferences. As of September, 30, 2018, there are 264,503 shares of Series B Preferred Stock outstanding.

Series C Preferred Stock

1,000,000 shares of preferred stock are designated as Series C Preferred Stock. Each share of Series C Preferred stock is convertible at the election of the holder into 100 shares of common stock. On October 23, 2015, (the “Amendment Date”), the Company amended the terms and conditions of the Series C Preferred stock, whereby each share of Series C Preferred stock entitles the holder thereof to 10,000 votes on all matters submitted to a vote of the stockholders of the Company. The Company determined that on the Amendment Date, the amended voting rights of the preferred stock resulted in a change of control of the Company. The holders of the Series C Preferred stock do not have any rights to dividends or any liquidation preferences. During the year ended March 31, 2016, the Company's CEO and another shareholder returned a total of 12,791 shares of common stock to the Company for cancellation in exchange for the issuance of 319,768 shares of Series C Preferred Stock. As of September, 30, 2018, there are 319,768 shares of Series C preferred stock outstanding, of which 223,768 shares are owned by our Chairman and CEO, Dr. Thomas Cellucci. On October 30, 2017, Dr. Cellucci, and Carebourn Capital L.P. executed Amendment No.1 to their Pledge Agreement, whereby, Dr. Cellucci, as collateral security, pledged 223,768 shares of his Series C Preferred Stock to Carebourn.

Series D Convertible Preferred Stock

On January 12, 2018, the Corporation amended its Articles of Incorporation (the “Articles of Amendment”) to designate a series of preferred stock, the Series D Convertible Preferred Stock (the “Series D Preferred Stock”). There were 100,000 shares of preferred stock designated as Series D Preferred Stock, $0.0001 par value. Each share of Series D Preferred Stock is convertible at the election of the holder into a number of shares of Corporation common stock equal to $24.00 divided by the volume-weighted average price of the common stock as reported on OTCMarkets.com on the trading day immediately preceding conversion, subject to a 4.99% beneficial ownership limitation. The holders of the Series D Preferred Stock do not have any rights to dividends or any liquidation preferences, and they do not have any voting rights prior to conversion into common stock. The Company issued in the aggregate 100,000 shares of the Series D Preferred Stock to the sellers of HelpComm. As of September 30, 2018, there are 100,000 shares of Series D Preferred Stock outstanding. Pursuant to the Purchase Price Allocation of the HelpComm acquisition, the fair value of the 100,000 Series D Preferred shares was estimated to be $2,400,000, which the Company has recorded as a long- term liability because the Series D Preferred shares represent an obligation to issue a variable number of shares based on a fixed dollar amount upon conversion.

Series E Preferred Stock

Table of Contents

Convertible Notes

On December 19, 2014, the Company issued a convertible back-end note, with a face value of $156,000 and stated interest of 8% to a third-party investor due December 19, 2015. The note is convertible at any time into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. The note was funded on June 18, 2015, when the Company received proceeds of $143,333, net of $12,663 of OID and costs. As of June 30, 2018, the outstanding principal amount of the note was $135,371.

On May 1, 2017, the Company issued to a third-party investor, three convertible notes, two of which were for $50,000 each and one for $17,500, and three back-end convertible notes, two of which were for $50,000 each and one for $25,000. All of the notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion subject to a ceiling of $0.0005. The three convertible notes were funded on May 1, 2017, when the Company received proceeds of $111,625, after disbursements for the lender’s transaction costs, fees and expenses of $5,875, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the three notes resulted in an initial debt discount of $117,500, an initial derivative expense of $319,692 and an initial derivative liability of $437,192. As of June 30, 2018, the outstanding principal balance of the three convertible notes was $117,500. On August 8, 2017, the investor funded the $25,000 back-end note when the Company received $23,750 after disbursements for the lender’s transaction costs, fees and expenses of $1,250, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the $25,000 back-end resulted in an initial debt discount of $25,000, an initial derivative expense of $258,904 and an initial derivative liability of $283,904. As of June 30, 2018, the outstanding principal balance of the convertible notes was $25,000.

On May 2, 2017, the Company issued a convertible note for legal services previously provided with a face value of $23,000 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 70% of the average of the three lowest closing bid prices for 10 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $15,715 and an initial derivative liability of $15,715. The investor sold the note to a third party on May 3, 2017, and the Company issued a replacement note to the buyer, as described below.

On May 3, 2017, the Company issued three replacement notes to a third-party investor. The replacement notes were in the amounts of $22,000, $29,700 and $25,300, respectively, and replaced notes issued in the amounts of $20,000, $27,000 and $23,000, respectively, all due May 3, 2018. The three replacement notes have a stated interest of 8% and each note is convertible at any time into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six- month anniversary of the notes the conversion price shall have ceiling of $0.0005. The embedded conversion feature included in the three replacement notes resulted in an initial debt discount of $77,000, an initial derivative expense of $158,790 and an initial derivative liability of $235,790. As of June 30, 2018, the principal balance of the three replacement notes in the aggregate was $77,000.

On June 8, 2017, the Company issued to a third-party investor a convertible promissory note for $140,750 and a back-end convertible note for $140,750. The notes mature on June 8, 2018, have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six-month anniversary of the note the conversion price shall have ceiling of $0.0005. The note was funded on June 15, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses of $5,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $140,750, an initial derivative expense of $454,574 and an initial derivative liability of $595,324. During the six months ended June 30, 2018, the investor converted $60,200 of principal and $2,916 of accrued interest into 60,398,076 shares of common stock. On January 26, 2018, the investor sold the remaining principal portion of the note of $80,550 and accrued interest of $3,920, and the Company issued a replacement note of $84,469 to the buyer (see below). As of June 30, 2018, the principal balance of the initial note is $-0-. On August 8, 2017, the investor funded the $140,750 back-end note when the Company received $135,000 after disbursements for the lender’s transaction costs, fees and expenses of $5,750, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the back-end resulted in an initial debt discount of $140,750, an initial derivative expense of $1,454,021 and an initial derivative liability of $1,594,771. During the six months ended June 30, 2018, the investor converted $140,750 of principal and $5,152 of accrued interest into 139,618,981 shares of common stock. As of June 30, 2018, the outstanding principal balance of the back-end convertible note was $-0-.

Table of Contents

On June 9, 2017, the Company issued a convertible promissory note, with a face value of $165,025 and stated interest of 10% to a third-party investor. The note is convertible at any time after ninety days following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on May 12, 2017, when the Company received proceeds of $135,000, after OID of $21,525, and disbursements for the lender’s transaction costs, fees and expenses of $8,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $143,500, an initial derivative expense of $134,496 and an initial derivative liability of $277,996. The note also requires 240 daily payments of $680 per day via ACH, however, there were no payments made for the six months ended June 30, 2018. As of June 30, 2018, the outstanding principal balance of the note was $-0-.

On June 23, 2017, the Company issued a convertible promissory note, with a face value of $262,775 and stated interest of 10% to a third-party investor. The note is convertible at any time after ninety days following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on June 23, 2017, when the Company received proceeds of $220,000, after OID of $34,275, and disbursements for the lender’s transaction costs, fees and expenses of $8,500, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $228,500, an initial derivative expense of $187,733 and an initial derivative liability of $416,233. The note also required 180 daily payments of $1,460 per day via ACH. As of June 30, 2018, the outstanding principal balance of the note was $-0-.

On August 7, 2017, the Company issued a convertible promissory note, with a face value of $223,422, maturing on August 7, 2018, and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note was funded on August 9, 2017, when the Company received proceeds of $186,280, after OID of $29,142, and disbursements for the lender’s transaction costs, fees and expenses of $8,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The note also requires 240 daily payments of $931 per day via ACH, no payments were made on the note. The embedded conversion feature included in the note resulted in an initial debt discount of $194,280, an initial derivative expense of $112,250 and an initial derivative liability of $306,530. On March 27, 2018, the investor sold $26,400 of the note to a third party (see below). As of June 30, 2018, the note balance is $-0-.

On October 12, 2017 (the “Issue Date”), the Company issued a convertible promissory note, with a face value of $40,111 maturing October 12, 2018, and stated interest of 12% to a third-party investor. The note is convertible at any time following ninety (90) days after the Issue Date of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $40,111, an initial derivative expense of $35,941 and an initial derivative liability of $76,052. On April 2, 2018, the Company paid $45,000, including $4,889 of interest and prepayment costs. As of June 30, 2018, the note balance of this note is $-0-.

Table of Contents

On November 1, 2017, the Company issued a convertible promissory note, with a face value of $239,200 maturing November 1, 2018, and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note was funded on November 1, 2017, when the Company received proceeds of $200,000, after OID of $31,200, and disbursements for the lender’s transaction costs, fees and expenses of $8,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $208,000, an initial derivative expense of $233,718 and an initial derivative liability of $441,718. The note also requires 240 daily payments of $997 per day via ACH, no payments have been made on the note. As of June 30, 2018, the note balance is $-0-.

On November 9, 2017, the Company issued a convertible promissory note, with a face value of $120,750, maturing on May 1, 2018, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on November 10, 2017, when the Company received proceeds of $100,000, after OID of $15,750, and disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $105,000, an initial derivative expense of $41,897 and an initial derivative liability of $146,897. The note also requires daily payments of $503 until the note is paid in full, no payments have been made and the Company is in default of the note. As of June 30, 2018, the note balance is $120,750.

On December 26, 2017, the Company issued a convertible promissory note, with a face value of $120,750 and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note was funded on December 27, 2017, when the Company received proceeds of $100,000, after OID of $15,750, and disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $105,000, an initial derivative expense of $93,767 and an initial derivative liability of $198,767. The note also requires 240 daily payments of $503 per day via ACH, no payments have been made and the Company is in default of the note. As of June 30, 2018, the note balance is $120,750, with a carrying value of $58,892, net of unamortized discounts of $61,858.

On January 26, 2018, the Company issued a replacement convertible promissory note in the face amount of $84,469, to a third-party that replaced a portion of the convertible promissory note issued on June 8, 2017, with a face value of $80,550, and accrued interest of $3,913. The embedded conversion feature included in the replacement note resulted in an initial debt discount of $84,465, an initial derivative expense of $58,121 and an initial derivative liability of $142,586. As of June 30, 2018, the outstanding principal amount of the replacement note issued was $84,469, with a carrying value as of June 30, 2018, of $36,371, net of unamortized discounts of $48,098.

On January 26, 2018 (the “Issue Date”), the Company issued a convertible promissory note, with a face value of $20,000, maturing on January 26, 2019, and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note was funded on January 26, 2018, when the Company received proceeds of $20,000. The note also requires daily ACH payments of $83, no payments have been made and the Company is in default of the note. The embedded conversion feature included in the note resulted in an initial debt discount of $20,000, an initial derivative expense of $15,403 and an initial derivative liability of $35,403. As of June 30, 2018, the note balance is $20,000 with a carrying value as of June 30, 2018, of $8,611, net of unamortized discounts of $11,389.

On January 29, 2018, the Company issued a convertible promissory note, with a face value of $84,525, maturing on July 29, 2018, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on February 5, 2018, when the Company received proceeds of $70,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires daily ACH payments of $263, no payments have been made and the Company is in default of the note. The embedded conversion feature included in the note resulted in an initial debt discount of $89,525, an initial derivative expense of $7,909 and an initial derivative liability of $97,434. As of June 30, 2018, the note balance is $84,525 with a carrying value as of June 30, 2018, of $64,466, net of unamortized discounts of $20,059.

Table of Contents

On February 21, 2018, the Company issued a convertible promissory note, with a face value of $184,000, maturing on February 21, 2019, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on February 21, 2018, when the Company received proceeds of $150,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires daily ACH initial payments of $250 for the first 30 days, then an increase to a daily ACH range of $251 to $766. During the six months ended June 30, 2018, the Company made principal payments of $20,250. The embedded conversion feature included in the note resulted in an initial debt discount of $198,000, an initial derivative expense of $114,501 and an initial derivative liability of $312,501. As of June 30, 2018, the note balance is $163,750 with a carrying value as of June 30, 2018, of $36,700, net of unamortized discounts of $127,050.

On April 2, 2018 (the “Issue Date”), the Company issued a convertible promissory note, with a face value of $45,000, maturing on April 2, 2019, and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note also requires daily ACH payments of $83, no payments have been made and the Company is in default of the note. The embedded conversion feature included in the note resulted in an initial debt discount of $45,000, an initial derivative expense of $32,083 and an initial derivative liability of $77,083. As of June 30, 2018, the note balance is $45,000 with a carrying value as of June 30, 2018, of $11,125, net of unamortized discounts of $33,875.

On April 8, 2018, the Company issued a convertible promissory note, with a face value of $34,500, maturing on October 8, 2018, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on April 10, 2018, when the Company received proceeds of $30,000, after disbursements for the lender’s transaction costs, fees and expenses. The embedded conversion feature included in the note resulted in an initial debt discount of $34,500, an initial derivative expense of $29,712 and an initial derivative liability of $64,212. As of June 30, 2018, the note balance is $34,500 with a carrying value as of June 30, 2018, of $15,908, net of unamortized discounts of $18,592.

On May 11, 2018, the Company issued a convertible promissory note, with a face value of $215,000, maturing on May 11, 2019, (the “Maturity Date”) and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on May 11, 2018, when the Company received proceeds of $200,000, after disbursements for the lender’s transaction costs, fees and expenses. The embedded conversion feature included in the note resulted in an initial debt discount of $215,000, an initial derivative expense of $40,845 and an initial derivative liability of $255,845. As of June 30, 2018, the note balance is $215,000 with a carrying value as of June 30, 2018, of $16,944, net of unamortized discounts of $198,056.

On May 18, 2018, the Company issued a convertible promissory note, with a face value of $52,969, maturing on November 18, 2018, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on May 18, 2018, when the Company received proceeds of $42,000, after disbursements for the lender’s transaction costs, fees and expenses. The embedded conversion feature included in the note resulted in an initial debt discount of $42,000, an initial derivative expense of $16,011 and an initial derivative liability of $58,011. As of June 30, 2018, the note balance is $52,969 with a carrying value as of June 30, 2018, of $12,653, net of unamortized discounts of $40,316.

On June 15, 2018, the Company issued a convertible promissory note, with a face value of $63,000, maturing on December 15, 2018, (the “Maturity Date”) and stated interest of 10% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note also requires daily ACH payments of $350 beginning on August 15, 2018.The note was funded on June 15, 2018, when the Company received proceeds of $50,000, after OID of $8,000, and disbursements for the lender’s transaction costs, fees and expenses of $5,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $58,000, an initial derivative expense of $26,864 and an initial derivative liability of $84,864. As of June 30, 2018, the note balance is $63,000 with a carrying value as of June 30, 2018, of debit balance of $2,083, net of unamortized discounts of $65,083.

On June 20, 2018, the Company issued a convertible promissory note, with a face value of $184,000, maturing on June 20, 2019, (the “Maturity Date”) and stated interest of 12% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note also requires daily ACH payments of $350. During the six months ended June 30, 2018, principal payments of $2,100 were made. The note was funded on June 20, 2018, when the Company received proceeds of $150,000, after OID of $24,000, and disbursements for the lender’s transaction costs, fees and expenses of $10,000, which were recorded as discounts against the debt to be amortized into interest expense through maturity. The embedded conversion feature included in the note resulted in an initial debt discount of $160,000, an initial derivative expense of $42,071 and an initial derivative liability of $202,071. As of June 30, 2018, the note balance is $181,900 with a carrying value as of June 30, 2018, of a debit balance of $6,711, net of unamortized discounts of $188,611.

Table of Contents

A summary of the convertible notes payable balance as of June 30, 2018, is as follows:

	June 30, 2018
Principal balance	$	1,770,016
Unamortized discounts		(777,775	)
Ending balance, net	$	992,241

Penny Stock Considerations

Our shares will be considered "penny stocks" as that term is generally defined in the Securities Exchange Act of 1934 to mean equity securities with a price of less than $5.00 per share. Thus, our shares will be subject to rules that impose sales practice and disclosure requirements on broker-dealers who engage in certain transactions involving a penny stock. Under the penny stock regulations, a broker-dealer selling a penny stock to anyone other than an established customer must make a special suitability determination regarding the purchaser and must receive the purchaser's written consent to the transaction prior to the sale, unless the broker-dealer is otherwise exempt.

In addition, under the penny stock regulations, the broker-dealer is required to:

	·	Deliver, prior to any transaction involving a penny stock, a disclosure schedule prepared by the Securities and Exchange Commission relating to the penny stock market, unless the broker-dealer or the transaction is otherwise exempt;
	·	Disclose commissions payable to the broker-dealer and our registered representatives and current bid and offer quotations for the securities;
	·	Send monthly statements disclosing recent price information pertaining to the penny stock held in a customer’s account, the account’s value, and information regarding the limited market in penny stocks; and
	·	Make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction, prior to conducting any penny stock transaction in the customer’s account.

Because of these regulations, broker-dealers may encounter difficulties in their attempt to sell shares of our common stock, which may affect the ability of selling shareholders or other holders to sell their shares in the secondary market and have the effect of reducing the level of trading activity in the secondary market. These additional sales practice and disclosure requirements could impede the sale of our securities, if our securities become publicly traded. In addition, the liquidity for our securities may be decreased, with a corresponding decrease in the price of our securities. Our shares in all probability will be subject to such penny stock rules and our shareholders will, in all likelihood, find it difficult to sell their securities.

Item 10. INTERESTS OF NAMED EXPERTS AND COUNSEL

The audited financial statements for the Company for the nine months ended December 31, 2017, and the year ended March 31, 2017, included in this prospectus have been audited by D. Brooks and Associates CPA’s, P.A., an independent registered public accounting firm, to the extent and for the periods set forth in our report and are incorporated herein in reliance upon such report given upon the authority of said firm as experts in auditing and accounting.

The legality of the shares offered under this registration statement is being passed upon by Brunson Chandler, & Jones, PLLC.

No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the common stock was employed on a contingency basis, or had, or is to receive, in connection with the offering, an interest, direct or indirect, in the registrant or any of its parents or subsidiaries. Nor was any such person connected with the registrant or any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.

Table of Contents

Item 11. INFORMATION WITH RESPECT TO THE REGISTRANT

Overview

Bravatek Solutions, Inc., a Colorado corporation (the “Company”), was incorporated on April 19, 2007. Effective October 23, 2015, the Company changed its name to “Bravatek Solutions, Inc.” in order to better reflect the Company's expanding operations and strategy. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services, and telecom services. Products include software, hardware and services, and span a diverse variety of industries including, but not limited to, email security, user authentication, telecommunications and cyber breach protection. Bravatek is a security platform company offering services, software, tools and systems that it provides, develops, acquires or obtains through strategic marketing or other agreements.

Principal Products

Bravatek’s primary business focus centers on security, defense, and information security solutions that assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructure against both physical and cyber-attacks. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, tools and systems (including services). To date, the Company has earned limited revenue. The Company believes the majority of its revenues will be derived from sales of proprietary and allied products and services to large enterprises, government, and military customers within the United States (“U.S.”) and abroad.

Currently, the Company's primary business operations are focused on establishing a strategic leadership position in cybersecurity email solutions and telecom services within the U.S. and abroad. The Company also has a “Market Alliance Program” (“MAP”) that enables Bravatek to rapidly introduce additional allied software, tools and systems to the worldwide marketplace through “win-win” contracts offering Bravatek, in most cases, exclusive distribution rights in specified markets.

Currently, the Company's primary proprietary product development efforts are focused on enhancing its patent-pending, sales-released, enterprise-level information security software appliance called Ecrypt One . It was designed to protect email and attachments in transit and at rest. It incorporates and supports multiple security technologies and techniques, such as encryption, role-based access controls, server rules that enforce security, and multi-factor authentication. It was designed, with our rigorous new product development process, to assist organizations and governments to meet and maintain compliance with information security regulations, such as the Health Insurance Portability and Accountability Care Act of 1996 (“HIPAA”). Additionally, during the second quarter of 2018, the Company began taking pre-orders for Tuitio , a consumer software cybersecurity anti-malware product (protected by two issued patents) developed by one of the Company’s strategic alliance partners, AppGuard LLC, which the Company has the right to white label and distribute in the consumer market.

On June 2, 2015, the Company completed an acquisition of some of the assets of Viking Telecom Services, LLC (“Viking Telecom”), which allowed the Company to provide telecom services under the Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G/5G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. On January 12, 2018, the Company acquired HelpComm, Inc., a Virginia corporation, and the Company now provides the telecom services described above under the HelpComm brand.

During the first quarter of 2018, the Company formed a joint venture entity (the “DarkPulse Joint Venture”) with DarkPulse Technologies, Inc. (“DarkPulse”), subsequently funding the Joint Venture approximately $87,000. The DarkPulse Joint Venture, owned 40% by Bravatek and 60% by DarkPulse, has the right to use DarkPulse’s BODTA (Brillouin Optical Time Domain Analysis) technology in several geographic locations and was formed to develop, market and sell BODTA-based technology systems consisting of both hardware and software, principally for applications involving protection of critical infrastructure and key resources.

Research and Development

Over the next twelve (12) months, Bravatek will continue developing new strategic alliances and strengthening existing strategic alliances. The Company also plans to continue developing enhancement upgrades to its proprietary enterprise-focused cybersecurity product, Ecrypt One , as well the consumer cybersecurity product, Tuitio . The Company may also continue to fund the development and production efforts of the DarkPulse Joint Venture.

Production

Ecrypt One was developed using a proprietary, rigorous new product development process under the supervision of the Company’s CEO, Dr. Thomas A. Cellucci and Vice President of Product Development, Ian Treleaven. Tuitio was developed by one of the Company’s strategic alliance partners, AppGuard LLC, and the Company has the right to white label (private label) and distribute it in the consumer market. Solution testing and evaluation (“T&E”) is routinely conducted by Ian Treleaven and the Company's development consultants using industry-standard tools and methods. The Company engages in technical meetings to address feedback from all T&E activities.

Distribution

The Company distributes its solutions globally, in accordance with applicable import and export regulations, through a number of distribution channels. The primary method of distribution is through a dedicated in-house sales team with a network of representatives. The Company is also pursuing strategic distribution alliances with data centers, service providers, carrier dealers, consultants, and complementary solution providers to distribute its product.

Additionally, the Company intends to list its solutions on the General Services Administration (“GSA”) Schedules or other government contract vehicles for acquisition by authorized users. GSA is an independent agency of the United States government that, amongst other responsibilities, supplies products and communications for US government offices. The Company had its software related products and capabilities listed on the SEWP contract vehicle, administered by NASA, useable by many civilian and military agencies in the U.S.

Table of Contents

Customers and Marketing

Customers

The Company offers products and services in multiple segments in government, business, and consumer markets. The majority of the allied products and services are targeted at government, military and business markets.

The Company will primarily target Fortune 100 and 500 enterprises within the healthcare, financial/legal services, and telecommunications industries, as well as government, military and law enforcement agencies. These organizations have a critical reliance on security, defense, information security and data integrity products and services, and are subject to numerous stringent information security regulations.

The Company anticipates that a majority of its customers will be large sized businesses. The Company also anticipates sales of its products and services to U.S. government and military organizations and allied foreign government and military organizations like NATO.

To date, the Company has received and fulfilled orders from corporate customers for Ecrypt One and telecom services, as well as orders from consumers for Tuitio .

Marketing

Over the next twelve months, the Company will focus on orders and sales for its products and services. It will also continue to grow its strategic alliance network of allied products and service providers, who will also market Bravatek's products.

The Company will focus its marketing efforts on customer acquisitions of Ecrypt One and expansion of its telecom services division, as well as allied products and services. The Company anticipates that it will continue to market its proprietary and allied products on the Internet, using the Company's website (www.bravatek.com, not incorporated in this filing except as a reference), on social networking sites like Facebook and Twitter, and on industry websites, blogs and forums.

The Company also intends to expand its sales capabilities.

Competition

Ecrypt One , the Company's enterprise-level information security server software package, is a unique offering that faces indirect competition from companies such as: i) Symantec Corporation; ii) Voltage Security; iii) Proofpoint Inc.; iv) Axway Software; v) Watchguard; and, vi) Zix Corporation.

All of the aforementioned companies develop and distribute email security servers. Although there is no assurance that we will be able to successfully compete with these organizations, our foremost advantage over these products is that Ecrypt One unifies multiple technologies and benefits (including email, encryption, anti-virus, anti-malware, no spam and no phishing) into a single solution making its use and administration more effective and efficient.

Allied products and services and the Company’s telecom services face competition from a variety of companies, many of which are better capitalized than the Company and which have, in many cases, significantly greater market penetration. Our telecom services competition is comprised of mainly smaller firms like Patriot Towers, American Tower and Crown Castle. Tuitio , the Company’s white label consumer anti-malware security software, competes with antimalware software from larger firms such as Kaspersky Lab, Bitdefender, and Webroot.

Although there is no assurance that we will be able to successfully compete with these organizations, our foremost advantage over competition is our network of potential customers, our ability to access them, and the diversity of high-tech products and services that the Company offers.

Intellectual Property and Agreements

Patents

The Company has filed patent applications for multiple attributes and processes contained in Ecrypt One . Bravatek’s white-labeled Tuitio product is covered by two patents with 44 claims.

Licenses

The research, development and commercialization of cybersecurity software often involve alternative development and optimization routes, which are presented at various stages in the development process. The preferred routes cannot be predicted at the outset of a research and development program because they will depend upon subsequent discoveries and test results. There are numerous third-party patents in our field, and it is possible that to pursue the preferred development route of one or more of our products we will need to obtain a license to a patent, which would decrease the ultimate profitability of the applicable product. If we cannot negotiate a license, we might have to pursue a less desirable development route or terminate the program altogether.

Table of Contents

Trade Secrets

The Company also relies on trade secrets, proprietary know-how, and continuing technological innovation to develop and maintain a competitive position in our product areas. Bravatek employees, consultants and officers must sign a non-disclosure agreement before they are authorized to discuss particulars of the functionality of the Company's software products. All current employees, consultants and officers of the Company who are privy to confidential information have signed non-disclosure and non-competition agreements with the Company.

Environmental Issues

Through the provision of telecom services, the Company currently assists private sector clients to safely maintain, upgrade and install telecommunication towers, assemblies, and parts to enhance communications and protect the environment.

The Company's software products and their production or provision thereof, do not directly impact the environment. Notwithstanding the foregoing, the Company strives to be environmentally friendly in all aspects of its operations.

Governmental Regulations

Telecom services work is governed by the United States Occupational Safety and Health Administration (“OSHA”). OSHA is a federal organization (part of the United States Department of Labor) that ensures safe and healthy working conditions for Americans by enforcing standards and providing workplace safety training.

Created in response to the Occupational Safety and Health Act of 1970, OSHA's main goal is to protect the rights and safety of workers by preventing workplace injuries and deaths and holding employers accountable for safe workplaces. OSHA provides workers and employers with information about hazardous working conditions and they offer free assessment for workplace dangers.

There is a strict set of federal safety standards to which all businesses must adhere. These regulations cover things like disposal of hazardous materials, required personal safety equipment such as safety goggles, permitted noise levels and fall protection. OSHA inspects workplaces to ensure they're following all regulations to reduce chances of accident or injury.

Cybersecurity software is classified as a “dual-use good,” meaning that it can be used by both the general public and the military. Export of such goods is regulated by the Wassenaar Arrangement on Export Controls for Conventional Arms and Dual-Use Goods and Technologies (the “Wassenaar Arrangement”).

The Wassenaar Arrangement was established in order to contribute to regional and international security and stability by promoting transparency and greater responsibility in transfers of conventional arms and dual-use goods and technologies, thus preventing destabilizing accumulations. Participating States seek, through their national policies, to ensure that transfers of these items do not contribute to the development or enhancement of military capabilities, which undermine these goals, and are not diverted to support such capabilities.

The Participating States of the Wassenaar Arrangement include: Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, Netherlands, New Zealand, Norway, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom and United States.

In the United States, the Bureau of Industry and Security (“BIS”) is responsible for implementing and enforcing the Export Administration Regulations (“EAR”), which regulate the export and re-export of most commercial items. Encryption software is subject to the EAR and other U.S. law, and may not be exported or re- exported to certain countries (currently Cuba, Iran, North Korea, Sudan and Syria) or to persons or entities prohibited from receiving US exports. Because of this, the Company has applied and has received approval for Mass Market Status Export Authorization from the BIS. Mass Market Status is given to encryption products, which have been reviewed and classified by the BIS as exportable under certain rules and regulations, including the mass market encryption rules of the EAR.

The procurement and use of commercially available security solutions by government, and military agencies is controlled through various regulations. In order to provide or sell a service or product to a government or military agency, a vendor or provider can be approved by and listed with the United States General Services Administration (“GSA”) or other US government contract vehicles. Additionally, military applications also require that products be certified by the National Security Agency. The Company is pursuing such certifications and accreditations.

Table of Contents

Employees

The Company currently has one full-time employee, its Chief Executive Officer, Dr. Thomas A. Cellucci. Deborah King is contracted to act as Chief Financial Officer. Ian Treleaven is contracted to act as Vice President of Product Development of the Company. Various consultants have been contracted to fulfill sales, software development and web programming duties, and its subsidiary, HelpComm, Inc., has 28 employees in Virginia.

Reports to Security Holders

Once filed with the SEC, the Company provides its annual report that includes its audited financial information to its shareholders upon written request. The Company also makes its financial information equally available to any interested parties or investors through compliance with the disclosure rules of the Exchange Act. The Company is subject to disclosure filing requirements including filing Form 10-K's annually and Form 10-Q's quarterly. In addition, the Company files current reports on Form 8-K and other proxy and information statements from time to time as required.

The public may read and copy any materials that the Company files with the SEC at the SEC's Public Reference Room at 100 F Street NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

Legal Proceedings

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

On or about March 27, 2018, Global Capital Partners, LLC (“Global”) sent a demand for payment of amounts allegedly owed by the Company to Global pursuant to several promissory notes and threatening legal action. The Company retained Texas litigation counsel and responded to the demand letter.

On September 7, 2018, the Company filed a claim against Liberated Solutions, Inc. d/b/a the Go Eco Group and Brian Conway for breach of contract and other causes of action in the County Court No. 2 for Travis County, Texas (case no. C-1-CV-18-008488), seeking approximately $55,000 in damages.

MARKET PRICE OF THE REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

The Company's shares are approved for trading on the OTCBB under the symbol “BVTK.” The following table sets forth the high and low bid prices of our common stock (USD) for the last two fiscal years as reported by the National Quotation Bureau and represents inter dealer quotations, without retail mark-up, mark-down or commission and may not be reflective of actual transactions:

	(U.S. $)
Transition period ended December 31, 2017	HIGH		LOW
Quarter ended December 31, 2017	$	0.0061	$	0.0018
Quarter ended September 30, 2017	$	0.0071	$	0.0016
Quarter ended June 30, 2017	$	0.0028	$	0.0001

Fiscal year ended March 31, 2017	HIGH		LOW
Quarter ended March 31, 2017	$	0.0001	$	0.0001
Quarter ended December 31, 2016	$	0.0004	$	0.0001
Quarter ended September 30, 2016	$	0.06	$	0.0003
Quarter ended June 30, 2016	$	0.50	$	0.03

Holders

As of September 30, 2018, there were 9,982,694,590 shares of common stock issued and outstanding held by approximately 144 shareholders of record.

Dividends

The Company has not declared or paid any cash dividends on its common stock during the nine months ended December 31, 2017, and the fiscal year ended March 31, 2017. There are no restrictions on the common stock that limit our ability to pay dividends if declared by the Board of Directors and the loan agreements and general security agreements covering the Company's assets do not limit its ability to pay dividends. The holders of common stock are entitled to receive dividends when and if declared by the Board of Directors, out of funds legally available therefore and to share pro-rata in any distribution to the stockholders. Generally, the Company is not able to pay dividends if after payment of the dividends, it would be unable to pay its liabilities as they become due or if the value of the Company's assets, after payment of the liabilities, is less than the aggregate of the Company's liabilities and stated capital of all classes.

Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

Explanatory Note

On September 22, 2018, management realized that there was an error in the reported financial statements of the Company on the June 30, 2018, Form 10-Q (the “Financial Statements”), as filed with the Securities and Exchange Commission (“SEC”) on August 14, 2018. The error was the non-inclusion of a convertible note issued to a third party (the “Lender”) on May 18, 2018, in the amount of $52,969. The Company received proceeds of $42,000 after disbursements for the Lender’s transaction costs, fees and expenses of $10,969. The Company also sent a wire transfer of $42,000 to DarkPulse BVTK LLC (“JV”), a joint venture entity, of which we are a member. In addition, we have concluded that the JV should be consolidated with Bravatek due to the common control of Bravatek and the JV as our CEO is also the Co-CEO of the other party in the JV. Additionally, Bravatek has the most at risk, due to the fact that all the monies the JV has received have come from Bravatek.

The Company has concluded that the above errors, considered both individually, and in the aggregate, was not material to our previously issued Financial Statements. Our materiality assessment took into consideration the guidance in Staff Accounting Bulletin No. 99 - Materiality (“SAB 99”). From a quantitative perspective, the errors had no impact on our loss per share for the three and six months ended June 30, 2018 and as noted below, a minimal impact on our loss from operations for the three and six months ended June 30, 2018 and on our total assets and total liabilities as of June 30, 2018.

Pursuant to the SAB 99 guidance, the Company completed the materiality analysis on the legal and accounting considerations. The accounting literature states that:

The omission or misstatement of an item in a financial report is material if, in the light of surrounding circumstances, the magnitude of the item is such that it is probable that the judgment of a reasonable person relying upon the report would have been changed or influenced by the inclusion or correction of the error.

Due to the above “surrounding circumstances” phrase, SAB 99 concludes that management must consider more than just the quantitative factors when considering materiality, qualitative factors must be considered too. Accordingly, the Company also performed a qualitative assessment and determined the materiality of the errors was not sufficient enough to require a restatement of the previously issued Financial Statements, based on all of the relevant facts and circumstances. Our approach conforms to the SEC’s and FASB’s long-standing emphasis that materiality cannot be reduced to a quantitative assessment.

SEC SAB 99, cites a list of quantitative factors that may be utilized when accessing materiality of a financial statement error, including:

Whether the misstatement masks a change in earnings or other trends

Whether the misstatement hides a failure to meet analyst’s expectations

Whether the misstatement changes a loss into income or vice versa

Whether the misstatement affects the registrant’s compliance with regulatory requirements

Whether the misstatement affects the registrant’s compliance with loan covenants or other contractual requirements

Whether the misstatement has the effect of increasing management’s compensation

Whether the misstatement involves concealment of an unlawful transaction

As stated above, the Company believes the errors were not material and should be corrected by a revision to previously issued financial statements but not a formal restatement and announcement of non-reliance. Accordingly, the Company is retrospectively reflecting the correction of the errors for the three and six months ended June 30, 2018, presented in this Form S-1 including Management’s Discussion and Analysis of Financial Condition and Results of Operation.

A summary of the financial impact is as follows:

Description	As adjusted			As reported			Change			Change %
Current assets	$	820,896		$	777,139		$	43,757			5.63	%
Total assets	$	4,141,959		$	4,098,202		$	43,757			1.07	%
Current liabilities	$	6,124,074		$	6,057,498		$	66,576			1.10	%
Total liabilities	$	8,787,282		$	8,720,706		$	66,576			0.76	%
Total shareholder's deficit	$	(4,645,323	)	$	(4,622,504	)	$	(22,819	)		0.49	%
Net loss three months ended June 30, 2018	$	(2,578,186	)	$	(2,555,367	)	$	(22,819	)		0.89	%
Net loss six months ended June 30, 2018	$	(2,113,200	)	$	(2,090,381	)	$	(22,819	)		1.09	%

Table of Contents

You should read the following discussion of our financial condition and results of operations in conjunction with financial statements and notes thereto included elsewhere in this prospectus. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this prospectus, particularly in the section labeled “Risk Factors.”

Certain statements in this report, including statements in the following discussion, are what are known as “forward looking statements,” which are basically statements about the future. For that reason, these statements involve risk and uncertainty since no one can accurately predict the future. Words such as “plans,” “intends,” “will,” “hopes,” “seeks,” “anticipates,” “expects” and the like often identify such forward looking statements but are not the only indication that a statement is a forward-looking statement. Such forward looking statements include statements concerning our plans and objectives with respect to the present and future operations of the Company, and statements which express or imply that such present and future operations will or may produce revenues, income or profits. Numerous factors and future events could cause the Company to change such plans and objectives or fail to successfully implement such plans or achieve such objectives or cause such present and future operations to fail to produce revenues, income or profits. Therefore, the reader is advised that the following discussion should be considered in light of the discussion of risks and other factors contained in this report on Form 10-K and in the Company’s other filings with the Securities and Exchange Commission. No statements contained in the following discussion should be construed as a guarantee or assurance of future performance or future results.

INTRODUCTION

On February 3, 2018, we changed our fiscal year end from March 31 ^st to December 31 ^st . The consolidated balance sheets data as of December 31, 2017, and March 31, 2017, are derived from our audited consolidated financial statements included elsewhere in prospectus and should be read in conjunction with such consolidated financial statements and related notes. The unaudited financial data for the nine months ended December 31, 2016, is presented solely for the purpose of providing meaningful comparisons with the audited nine-month transition period ended December 31, 2017.

Certain statements in this report, including statements in the following discussion, are what are known as “forward looking statements,” which are basically statements about the future. For that reason, these statements involve risk and uncertainty since no one can accurately predict the future. Words such as “plans,” “intends,” “will,” “hopes,” “seeks,” “anticipates,” “expects” and the like often identify such forward looking statements but are not the only indication that a statement is a forward looking statement. Such forward looking statements include statements concerning our plans and objectives with respect to the present and future operations of the Company, and statements which express or imply that such present and future operations will or may produce revenues, income or profits. Numerous factors and future events could cause the Company to change such plans and objectives or fail to successfully implement such plans or achieve such objectives, or cause such present and future operations to fail to produce revenues, income or profits. Therefore, the reader is advised that the following discussion should be considered in light of the discussion of risks and other factors contained in this prospectus. No statements contained in the following discussion should be construed as a guarantee or assurance of future performance or future results.

Overview and Plan of Operation

Bravatek Solutions, Inc., a Colorado corporation, was incorporated in the State of Colorado, on April 19, 2007. The Company provides security, defense, and information security solutions, which assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructures against error, and physical and cyber-attack. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services, and telecom services. Products include software, hardware and services, and span a diverse variety of industries including, but not limited to, email security, user authentication, telecommunications and cyber breach protection.

Currently, the Company's primary business operations are focused on establishing a strategic leadership position in cybersecurity email solutions and telecom services within the U.S. and abroad. The Company also has a “Market Alliance Program” (“MAP”) that enables Bravatek to rapidly introduce additional allied software, tools and systems to the worldwide marketplace through “win-win” contracts offering Bravatek, in virtually all cases, exclusive distribution rights in specified markets.

Additionally, the Company has developed and plans to continue selling an enterprise level secure email software appliance named Ecrypt One. Ecrypt One is an email server with integrated security technology. It was designed to protect email and attachments in transit and at rest. It incorporates multiple security technologies and techniques, such as encryption, role-based access controls, server rules that enforce security, and multi-factor authentication. It was designed to assist organizations and governments to meet and maintain compliance with information security regulations such as HIPAA.

Table of Contents

Additionally, the Company began taking pre-orders for Tuitio, a consumer software cybersecurity product (protected by two issued patents), in the second quarter of 2018.

In an effort to advance the business operations of the Company, over the next twelve (12) months the Company plans to undertake the following actions in the order in which they are listed:

	1.	Continue distribution on Ecrypt One Software packages;
	2.	Continue providing telecom services;
	3.	Continue distribution of allied products and services;
	4.	Continue developing strategic marketing alliance program; and
	5.	Continue development and testing of additional Ecrypt One features and capabilities.

The foregoing business actions are goals of the Company. There is no assurance that the Company will be able to complete any, or all, of the foregoing actions.

Results of Operations

Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).

For the Three and Six Months Ended June 30, 2018, Compared to the Three and Six Months Ended June 30, 2017

Revenue

For the three and six months ended June 30, 2018, the Company had revenues of $774,204 and $1,843,197, respectively, compared to $0 for the three and six months ended June 30, 2017. The 2018 revenues were comprised of revenues from HelpComm and related party sales of $24,837 for Bravatek.

Cost of Services

For the three and six months ended June 30, 2018, cost of services of $627,439 and $1,448,531, respectively, were related to the HelpComm revenues, and are comprised of materials, labor, sub-contractors and related expenses.

Operating Expenses

For the three and six months ended June 30, 2018, the Company had operating expenses of $2,902,782 and $3,591,870, respectively, compared to $171,809 and $243,366 for the three and six months ended June 30, 2017, respectively. The increase in operating expenses was predominantly attributable to $274,605 and $683,160, respectively, of HelpComm’s operating expenses for the three and six months ended June 30, 2018 and $63,853 and $127,706 for the three and six months ended June 30, 2018, respectively, related to the amortization of the intangible assets acquired in the HelpComm acquisition.

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Bravatek expenses	$	2,564,326	$	171,809	$	2,781,004	$	243,366
HelpComm expenses		274,605		-		683,160		-
Amortization of acquired assets		63,853		-		127,706		-
Total	$	2,902,782	$	171,809	$	3,591,870	$	243,366

Expenses for Bravatek for the three and six months ended June 30, 2018, include $2,333,140 related to the issuance of Series E Preferred Stock to the Company’s CEO (see Note 11 to the financial statements).

Table of Contents

Other Income (Expenses)

Other income, net, for the three and six months ended June 30, 2018 was $177,832 and $1,084,004, respectively, compared to other expense, net, of $8,273,423 and $7,939,017, respectively, for the three and six months ended June 30, 2017.

	Three months ended June 30,					Six months ended June 30,
	2018			2017		2018			2017
Interest expense	$	652,541		$	367.730	$	1,515,176		$	488,899
Loss (gain) on fair value of derivatives		(831,894	)		7,902,778		(2,609,253	)		7,443,912
Loss on debt extinguishment		3,021			-		23,021			-
Other expense (income)		(1,500	)		2,915		(12,948	)		6,206
Total	$	(177,832	)	$	8,273,423	$	(1,084,004	)	$	7,939,017

Included in interest expense for the three and six months ended June 30, 2018 is $595,241 and $1,397,325, respectively for amortization expense of debt discounts, and for the three and six months ended June 30, 2017, amortization of debt discounts was $176,616 and $194,430, respectively.

Net Loss

The Company had a net loss of $2,578,186 and $2,113,200 for the three and six months ended June 30, 2018, respectively, compared to net losses of $8,445,232 and $8,183,466 for the three and six months ended June 30, 2017, respectively. The decrease in the net loss for the three and six months ended June 30, 2018, compared to the three and six months ended June 30, 2017, was predominantly due to the changes in other income (expenses), detailed above, partially offset by the voting control value of the Series E Preferred Stock of $2,333,140.

Liquidity and Capital Resources

Currently, we have limited operating capital. The Company anticipates that it will require approximately $4,000,000 of working capital to complete all of its desired business activity during the next twelve months. The Company has earned limited revenue from its business operations. Our current capital and our other existing resources will be sufficient only to provide a limited amount of working capital, and, to date, the revenues generated from our business operations have not been sufficient to fund our operations or planned growth. As noted above, we will likely require additional capital to continue to operate our business, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our operations, business development and financial results.

For the six months ended June 30, 2018, we primarily funded our business operations with $626,600 of advances on our revolving line of credit as well as $757,000 of proceeds from convertible note financings. These proceeds funded our business operations and were also used to make payments on our revolving line of credit as well as to pay off existing debt of approximately $141,550, to fund $30,380 for our Agreement with MHC. We may conduct a private placement offering to seek to raise additional working capital to continue to fund our business operations, and we may continue to rely on the issuance of convertible promissory notes to fund our business operations.

As of June 30, 2018, $65,485, as compared to $189,357 at December 31, 2017. As of June 30, 2018, we had current liabilities of $6,124,074 (including $2,291,409 of non-cash derivative liabilities), compared to current assets of $820,996, which resulted in a working capital deficit of $5,303,178. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, derivative liabilities, revolving line of credit, bank term loans and notes payable.

Operating Activities

For the six months ended June 30, 2018, net cash used in operating activities was $804,208, compared to $299,969 for the six months ended June 30, 2017. For the six months ended June 30, 2018, our net cash used in operating activities was primarily attributable to the net loss of $2,113,200 adjusted by the non-cash expenses of the voting control value of the Series E Preferred Stock of $2,333,140 and amortization and depreciation expense of $1,704,430, and reduced by the non-cash gain of $2,609,253 on the fair value change of derivatives. Net changes of $119,325 in operating assets and liabilities increased the cash used in operating activities. For the six months ended June 30, 2017, our net cash used in operating activities was primarily attributable to the net loss adjusted by the loss on fair value of derivatives, amortization of debt discounts, non-cash interest and fees related to convertible promissory notes and depreciation. Net changes of $137,865 in operating assets and liabilities impacted the cash flows from operating activities.

Investing Activities

For the six months ended June 30, 2018, cash used in investing activities of $18,660 was comprised of payments of $30,380 towards the Company’s exclusivity agreement with MHC, the purchase of a note receivable of $25,000 and purchased fixed assets of $10,190. For the six months ended June 30, 2017, the Company invested $200,000 in a strategic alliance with HelpComm.

Table of Contents

Financing Activities

For the six months ended June 30, 2018, the net cash provided by financing activities was $698,996, compared to $565,518 for the six months ended June 30, 2017. During the six months ended June 30, 2018, we received advances of $626,600 on our revolving line of credit and $757,000 from the issuance of $882,894 of convertible notes. The Company made payments of $543,054 on the revolving line of credit and made payments of $141,550 against notes payable, capital leases payable and convertible notes payable. The net cash provided by financing activities of $565,518 for the six months ended June 30, 2017, resulted from proceeds of $948,250 from the issuances of convertible notes and $11,301 from related party notes. The company made payments of $355,882 against notes payable and convertible notes payable and $38,151 repayments of notes payable- related.

For the Nine Months Ended December 31, 2017, Compared to the Nine Months Ended December 31, 2016

Revenue

For the nine months ended December 31, 2017, the Company had revenues of $64,897 compared to $203,054 for the nine months ended December 31, 2016. The 2017 revenues were related parties and included the sale of licensed software, hosting and support as well as the installation. The 2016 period included related party revenue of $145,362 for sales to a company that, at the time, was a significant shareholder of the Company and revenues of $23,625 were recorded in barter transactions in exchange for advertising and promotional expenses.

Operating Expenses

For the nine months ended December 31, 2017, the Company had operating expenses of $706,341 compared to $473,029 for the nine months ended December 31, 2016. The increase in operating expenses was attributable to an increase in depreciation and amortization, as the current period includes amortization of $175,244 related to the exclusive rights purchased from HelpComm and MHC.

Other Income (Expenses)

Other expenses for the nine months ended December 31, 2017, was $10,336,804 compared to $1,171,839 for the nine months ended December 31, 2016. The increase was primarily due to an increase of derivative expense to $8,603,969 for the nine months ended December 31, 2017, compared to $391,263 for the nine months ended December 31, 2016. Derivative expense for the nine months ended December 31, 2017, was a result of the initial derivative expense of $6,198,770 predominantly caused by the ceiling of $0.0005 as a conversion price on certain of the convertible promissory notes issued during the nine months ended December 31, 2017, and the fair value change in derivative liabilities of $2,405,199. Amortization expense of debt discounts increased to $1,401,597 for the nine months ended December 31, 2017, from $609,109 for the nine months ended December 31, 2016, as a result of the amortization of debt discounts recorded on newly issued convertible notes. Interest expense increased to $363,000 for the nine months ended December 31, 2017, from $177,555 for the nine months ended December 31, 2016, as a result of higher face value convertible note balances. Lastly, the Company recognized a gain on debt settlements of $63,727 for the nine months ended December 31, 2017.

Net Income / Loss

The Company had a net loss of $10,982,615 for the nine months ended December 31, 2017, compared to a net loss of $1,596,162 for the nine months ended December 31, 2016. The increase in net loss for the nine months ended December 31, 2017, compared to the nine months ended December 31, 2016, was predominantly due to the increases in other expenses as above.

Liquidity and Capital Resources

For the nine months ended December 31, 2017, we primarily funded our business operations with $2,002,030 of proceeds from convertible note financings. The proceeds funded our business operations and were also used to pay off existing debt of approximately $752,095 (including $154,651 to the Company’s CEO), and to fund $200,000 and $107,520 for our Strategic Alliance Agreements with HelpComm and MHC, respectively. We intend to secure additional working capital through our Equity Purchase Agreement with Triton, and we may also conduct a private placement offering or continue to rely on the issuance of convertible promissory notes to further fund our business operations.

As of December 31, 2017, we had cash of $189,357, as compared to $125 at March 31, 2017. As of December 31, 2017, we had current liabilities of $7,677,612 (including $5,331,567 of non-cash derivative liabilities) compared to current assets of $262,334 which resulted in working capital deficit of $7,415,278. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, derivative liabilities, accounts payable-related party and notes payable.

Table of Contents

Operating Activities

For the nine months ended December 31, 2017, net cash used in operating activities was $720,164 compared to $77,612 for the nine months ended December 31, 2016. For the nine months ended December 31, 2017, our net cash used in operating activities was primarily attributable to the net loss adjusted by loss on the fair value of derivatives, amortization of debt discounts, non-cash interest and fees related to convertible promissory notes and depreciation. Net changes of $14,222 in operating assets and liabilities increased the cash used in operating activities. For the nine months ended December 31, 2016, our net cash used in operating activities was primarily attributable to the net loss adjusted by amortization of debt discounts, derivative liability expenses non-cash interest and fees related to convertible promissory notes and depreciation. Net changes of $386,600 in operating assets and liabilities positively impacted the cash flows from operating activities.

Investing Activities

For the nine months ended December 31, 2017, the Company invested $200,000 and $107,520 in strategic alliances with HelpComm and MHC, respectively, as well as $25,000 in a joint venture with The Eco Group. There was no investing activity for the nine months ended December 31, 2016.

Financing Activities

For the nine months ended December 31, 2017, the net cash provided by financing activities was $1,266,916 compared to $62,626 for the nine months ended December 31, 2016. During the nine months ended December 31, 2017, we received proceeds of $2,020,030 from the issuance of $2,286,397 of convertible notes. The proceeds were used in operations and to pay $268,872 of convertible notes, $328,662 of notes payable and $154,651 of notes payable-related party. The results for the 2016 period was the result of proceeds received of $48,000 from the issuance of $61,239 of convertible promissory notes, receipt of $26,850 of proceeds from a related party loan and the repayment of $12,224 against convertible promissory notes.

Off Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition or results of operations.

Significant Accounting Policies Basis of Presentation

On February 3, 2018, the Board of Directors of the Company changed the Company’s fiscal year end to December 31 ^st from March 31 ^st . On May 3, 2018, the Company filed a Transition Report on Form 10-KT covering the nine-month period from April 1, 2017, through December 31, 2017 (the “Transition Period”), which reflects the Company’s financial results during that nine-month period.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.

Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates.

Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The Company had no cash equivalents.

Accounts Receivable/Allowance for Doubtful Accounts

The Company records its client receivables and unbilled services at their face amounts less allowances. On a periodic basis, the Company evaluates its receivables and unbilled services and establishes allowances based on historical experience and other currently available information. As of June 30, 2018, and December 31, 2017, management determined to establish an allowance for doubtful accounts of $30,000. The Company has engaged a law firm to pursue the collection of the $30,000.

Property and Equipment

Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

Software Development Costs

Costs for software developed for internal use are accounted for through the capitalization of those costs incurred in connection with developing or obtaining internal use software. Capitalized costs for internal use software are included in intangible assets in the consolidated balance sheet. Capitalized software development costs are amortized over three years.

Costs incurred during the preliminary project along with post-implementation stages of internal use computer software development and costs incurred to maintain existing product offerings are expensed as incurred. The capitalization and ongoing assessment of recoverability of development costs require considerable judgment by management with respect to certain external factors, including, but not limited to, technological and economic feasibility and estimated economic life. Capitalized software is amortized over the software's estimated economic life of 3 years. For the six months ended June 30, 2018, and 2017, the Company had no development costs required to be capitalized under ASC 985-20, Costs of Software to be Sold, Leased or Marketed, and under ASC 350-40, Internal-Use Software .

Long-Lived Assets

The Company reviews long-lived assets and certain identifiable intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.

Research and Development

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with GAAP. All research and development costs have been expensed as incurred, totaling $16,750 and $4,500 for the six months ended June 30, 2018 and 2017, respectively, and $6,750 and $2,250 for the three months ended June 30, 2018 and 2017, respectively.

Advertising and Promotions

The Company expenses advertising costs as incurred. Advertising expenses for the six months ended June 30, 2018, and 2017, was $700.

Fair Value of Financial Instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

Table of Contents

The following are the hierarchical levels of inputs to measure fair value:

	·	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

	·	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

	·	Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of June 30, 2018, and December 31, 2017, for each fair value hierarchy level:

June 30, 2018	Derivative Liability		Total
Level I	$	-	$	-
Level II	$	-	$	-
Level III	$	2,291,409	$	2,291,409

December 31, 2017
Level I	$	-	$	-
Level II	$	-	$	-
Level III	$	5,331,567	$	5,331,567

Embedded Conversion Features

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings.

If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.

Derivative Financial Instruments

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income.

For option-based simple derivative financial instruments, the Company uses the Monte Carlo simulations to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re- assessed at the end of each reporting period.

Debt Discount

The Company determined that the conversion feature of issued convertible notes represent an embedded derivative since the notes are convertible into a variable number of shares upon conversion. Accordingly, the notes were not considered to be conventional debt under EITF 00-19 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. The fair value of these derivative instruments are recorded as a liability on the consolidated balance sheet with the corresponding amount recorded as a discount to each Note. Such discount is being amortized from the date of issuance to the maturity dates of the Notes.

Revenue Recognition

Product revenue and miscellaneous income are recognized as earned.

The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-S99, Revenue Recognition, Overall, SEC Materials (“Section 605-10-S99”). Section 605-10-S99 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred, or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. The Company recognizes revenue from services at the time the services are completed. The Company’s sale of licensed software has significant standalone functionality with a perpetual right to use the Company’s intellectual property. Accordingly, the Company recognizes licensed software revenue at the time the software is delivered or available to the customer, at which time the company had no further obligations related to the sale of the software. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction.

Table of Contents

Stock-Based Compensation – Employees

The Company accounts for its stock-based compensation in which the Company obtains employee services in stock-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option pricing valuation model.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

On June 2, 2015, the Company completed an acquisition of some of the assets and assumed certain liabilities of Viking Telecom Services, LLC (“Viking Telecom”) from Dependable Critical Infrastructure, Inc. (“DCI,” f/k/a DTREDS Consolidated, Inc.). To acquire the assets, the Company issued 2,265 shares of common stock, 224 shares of common stock to be issued (valued in the aggregate at $740,000), paid $200,000 cash and forgave $59,204 of a note receivable from DCI. The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. At the time of the acquisition, our CEO owned approximately 30% of DCI. The Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016.

Net Earnings (Loss) per Share

Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted average number of common shares outstanding for a period, if dilutive. As of June, 30, 2018, there were warrants and options to purchase 3,365 shares of common stock and the Company’s outstanding convertible debt is convertible into approximately 2,567,730,355 shares of common stock. These amounts are not included in the computation of dilutive loss per share because their impact is antidilutive.

Table of Contents

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

We have had no disagreements with our accountants required to be disclosed pursuant to Item 304 of Regulation S-K.

On May 15, 2017, we notified Green & Company, CPAs (“Green”) of their dismissal as our independent registered public accounting firm. On May 15, 2017, we engaged D. Brooks and Associates CPA’s, P.A. (“Brooks”) of West Palm Beach, Florida, as our new independent registered public accounting firm. Green did not issue a report on our financial statements for either of the two fiscal years ending March 31, 2017, or March 31, 2016. Our Board of Directors participated in and approved the decision to change our independent registered public accounting firm. Through our fiscal years ending March 31, 2017 and 2016, there were no disagreements with Green on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of Green would have caused them to make reference thereto in their report on the financial statements. Through the interim period from March 31, 2017, to May 15, 2017, there were no disagreements with Green on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of Green would have caused them to make reference thereto in their report on the financial statements. During the years ended March 31, 2017, and the interim period through May 15, 2017, there were no reportable events with us as set forth in Item 304(a)(1)(iv) of Regulation S-K. During the fiscal years ended March 31, 2017 and 2016, and prior to May 15, 2017 (the date of our engagement of Brooks), we had not consulted with Brooks regarding any of the following: (i) the application of accounting principles to a specific transaction, either completed or proposed; (ii) the type of audit opinion that might be rendered on our consolidated financial statements, and none of the following was provided to us: (a) a written report, or (b) oral advice that Green concluded was an important factor considered by us in reaching a decision as to accounting, auditing or financial reporting issue; or (iii) any other matter that was the subject of a disagreement between us and our former auditor or was a reportable event (as described in Items 304(a)(1)(iv) or Item 304(a)(1)(v) of Regulation S-K, respectively).

CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company's controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC's rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

As of December 31, 2017, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are not designed to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of the achievement of these objectives.

Internal Control over Financial Reporting

The management of the Company also is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. A company's internal control over financial reporting is defined as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company's internal controls will prevent all error and all fraud. Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable, not absolute, assurance that the objectives of the control system are met and may not prevent or detect misstatements. Further, over time control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate.

With the participation of the Chief Executive Officer and Chief Financial Officer, our management evaluated the effectiveness of the Company's internal control over financial reporting as of December 31, 2017, based upon the framework in Internal Control -Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management has concluded that the Company's internal controls over financial reporting were not effective as of December 31, 2017.

This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm

Table of Contents

DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.

Directors, Executive Officers and Significant Employees

The following table sets forth, as of December 31, 2017, the respective positions and ages of our directors and executive officers of the Company. Each director has been elected to hold office until the next annual meeting of shareholders and thereafter until his successor is elected. Vacancies in the existing Board of Directors are filled by majority vote of the remaining Directors. There are no agreements or understandings for any officer or director to resign at the request of another person and no officer or director is acting on behalf of or will act at the direction of any other person.

Name	Age	Position	Director or Officer Since
Dr. Thomas A. Cellucci	60	Chief Executive Officer Director	June 17, 2014 March 27, 2014

Deborah King	58	Director CFO	March 16, 2015 August 6, 2015

Charles Brooks	61	Director	March 16, 2015

Hans Holmer	57	Director	September 1, 2015

Biographical Information

Dr. Thomas A. Cellucci - Dr. Thomas A. Cellucci (“Dr. Cellucci”) currently serves as the Chief Executive Officer and a Director of the Company. Additionally, from 1999 to the present, Dr. Cellucci serves as the Chairman and CEO of Cellucci Associates, a high tech marketing firm focused on developing business and marketing plans for worldwide high tech firms. Cellucci was appointed a Board member and co-CEO of DarkPulse Technologies in 2018, which was acquired in July of 2018 by DarkPulse, Inc., a Delaware corporation with a class of securities registered with the SEC pursuant to the Exchange Act of 1934. At the time of acquisition, Dr. Cellucci was appointed as a director of DarkPulse, Inc.

In 2017, Dr. Cellucci was elected the Chairman of the Board of Trustees of Eurasian Technological University in Almaty, Kazakhstan. He has been a member of the International Science and Commercialization Board for the World Bank since 2016. He is also the author or co-author of 25 books and over 192 technical and business articles.

From 2013 to the present, Dr. Cellucci served as the Executive Director at AGVE (Alliance for Government Virtual Engagements) located in Washington DC. AGVE is a non-profit dedicated to fostering technology-focused bridges, best practices and communications between government and the private sector to enable high performance/price business operations for government. He was also the Founding and Managing Partner of Union Core Technology Partners, a private equity fund.

From 2007 to 2011, Dr. Cellucci served as the First Chief Commercialization Officer of the United States of America, where he was responsible for overseeing the development and execution of programs and processes that identified, evaluated, and commercialized privately owned technologies into products or services that meet the needs of the Department of Homeland Security's (DHS) stakeholders, including DHS operating components and end users such as the nation's first responders, and critical infrastructure owner/operators.

During his tenure as the Chief Commercialization Officer, in 2010 Dr. Cellucci was also appointed as the Director of the Office of Public Private Partnerships, which oversees the Long Range Broad Agency Announcement (LRBAA) procurement process, Office of SAFETY Act Implementation (OSAI), Small Business Innovation Research (SBIR) Office as well as the Commercialization Office. At this same time, Dr. Cellucci was also named Executive Director of the Research and Development (R&D) Partnerships Group responsible to leverage the billions of dollars in assets and the expertise of more than 1300 team members through the group's investments in national labs, universities, international partners, the private sector and government interagency partners to develop technologies and products for the Homeland Security Enterprise (HSE).

Dr. Cellucci earned a PhD in Physical Chemistry from the University of Pennsylvania, an MBA from Rutgers University and a BS in Chemistry from Fordham University. He has also attended and lectured at executive programs at the Harvard Business School, MIT Sloan School, Kellogg School and others.

Between 1978 and 1991 Dr. Cellucci was Chemistry Lecturer at Fordham University, the University of Pennsylvania, and Princeton University, as well as Professor of Physics and Laser/Electro-Optic Technology at Camden County College. Since 2017, Cellucci holds the special rank of Honorary Professor (Endowed Chair) at two major universities in both business and technology.

Table of Contents

Deborah King (a/k/a Debbie King) - Ms. King possesses over 25 years of entrepreneurial leadership experience and has served as a business and financial advisor to a number of firms in her career. She currently serves as the Business Manager to a privately held firm in Dallas, Texas, and brought a unique set of skills to her position including financial, operations, and business management. Ms. King has assisted a number of firms in business start-up, acquisition, expansion, and reorganization. She possesses a diverse skill set that allows a broad perspective of business financial and operations management. Ms. King's background as an accountant has allowed her to serve numerous firms in various industries in optimizing profit outputs and streamlining business practices. She is a strong-minded and focused individual that utilizes her education and experience to assist in analyzing, identifying and implementing operational changes to increase efficiency and profits. Ms. King possesses a broad knowledge in financial, legal and business tax applications.

Charles Brooks (a/k/a Chuck Brooks) - Charles Brooks currently serves as the Vice President of Government Relations & Marketing for Sutherland Global Services. Mr. Brooks has extensive experience in Senior Executive Management, Government Relations, Research & Development, and Marketing/Business Development and worked in those capacities for three large public corporations. He also received Presidential Appointments from two Presidents, George W. Bush and Ronald Reagan, to serve in executive roles in the federal government. Mr. Brooks served at the Department of Homeland Security as the first Director of Legislative Affairs for the Science & Technology Directorate. Earlier in his career he served as Special Assistant to the Director of Voice of America. He also spent six years on Capitol Hill as a Senior Advisor to the late Senator Arlen Specter where he covered foreign affairs, business, and technology issues. In academia, Mr. Brooks was an Adjunct Faculty Member at Johns Hopkins University where he taught graduate level students about homeland security and Congress.

Mr. Brooks has an MA in International Relations from the University of Chicago, a BA in Political Science from DePaul University, and a Certificate in International Law from The Hague Academy of International Law. He is a featured speaker at conferences and is widely published on the subjects of cybersecurity, homeland security, innovation, public/private partnerships, and emerging technologies. Those publications include: Huffington Post, Forbes, Government Security News, The Hill, Federal Times, Government Executive, MIT Sloan Blog, Homeland Security Today, Biometric Update, NextGov, and Cygnus Media.

Hans Holmer - Mr. Holmer is a retired CIA officer with extensive experience in strategic cyber issues. His experience in nation-state intelligence collection and corporate defense goes back nearly 20 years and his engagement with the interface of humans and technology goes back to 1973. He spent over half of his career overseas and served on every continent except South America. Among other awards, Mr. Holmer has received the CIA Intelligence Star “in recognition of his especially valorous performance of duty.”

Within the cyber realm, Mr. Holmer became an expert in conventional computer networks, telephony, Industrial Control Systems, and defensive strategies. He developed the Cyber Security Hierarchy, analogous to the Maslow hierarchy of human needs, which outlines a hierarchy of needs that must be satisfied to achieve cyber security. It postulates that effective cyber security requires adequate resources, integration with the corporate business processes, esteem for cyber security requirements and the agility to respond to threats in order to have adequate impact.

From May of 2013 through the present, Mr. Holmer has worked for Intelligent Decisions, Inc., and before that, he worked for the Central Intelligence Agency. Mr. Holmer is not a director of any other public companies.

Family Relationships

None.

Involvement in Certain Legal Proceedings

To the best of its knowledge, the Company's directors and executive officers were not involved in any legal proceedings during the last ten years as described in Item 401(f) of Regulation S-K.

Directorships

Other than as disclosed above, none of the Company's executive officers or directors is a director of any company with a class of equity securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.

Compliance with Section 16(a) of the Exchange Act

Section 16(a) of the Exchange Act requires the Company’s directors and named executive officers, and persons who beneficially own more than 10% of a registered class of our equity securities to file initial reports of ownership and reports of changes in ownership of our common stock and our other equity securities with the SEC. Upon information and belief, our CEO did not file a Form 4 upon receipt of preferred shares on or about July 20, 2015 and June 1, 2018, our other directors did not file Form 3’s upon their appointment as directors of the Company on March 16, 2015 (for Ms. King and Mr. Brooks), and September 1, 2015 (for Mr. Holmer), and our directors did not file Form 4’s for the receipt of options described in Item 11 below.

Code of Ethics

The Company has adopted a code of ethics, as required by the rules of the SEC, a copy of the Company's code of ethics was filed as Exhibit 14.1 to Form 10-K for the fiscal year ended March 31, 2010, filed with the Securities and Exchange Commission on July 13, 2010, and which is hereby incorporated by reference. The code of ethics applies to all of the Company's senior financial officers. The code of ethics, and any amendments to, or waivers from, the code of ethics, is available in print, at no charge, to any stockholder who requests such information.

Table of Contents

ITEM 11. EXECUTIVE COMPENSATION .

Executive Compensation

The following table sets forth, for the nine months indicated, all compensation paid, distributed or accrued for services, including salary and bonus amounts, rendered in all capacities by the Company's chief executive officer, chief financial officer and all other executive officers who received or are entitled to receive remuneration in excess of $100,000 during the stated periods.

Name and principal position	For the Years Ending December 31,	Salary $		Stock Options $		Option Awards $		Total $
Dr. Thomas A Cellucci, CEO & Director (1)	2017		168,000		-0-		-0-		168,000
	2016		182,000		-0-		-0-		182,000

Deborah King, CFO, & Director (2)	2017		61,000		-0-		-0-		61,000
	2016		62,500		-0-		-0-		62,500

_________

(1)

Dr. Cellucci was named CEO of the Company on June 17, 2014. Pursuant to Dr. Cellucci’s employment agreement, as amended, the Company currently accrues compensation of $12,500 per month for his services as CEO of the Company. The Company also accrues $1,500 a month to Dr. Cellucci as reimbursement for health and dental insurance costs. On March 27, 2015, Dr. Cellucci was granted a warrant to purchase 1,200 shares of the Company's common stock at a $750 per share exercise price, exercisable on a cashless basis, having a term of 5 years, and vested immediately on March 27, 2015. As of December 31, 2017, the Company owed Dr. Cellucci $318,179 (included in accounts payable, related party on the December 31, 2017, balance sheet presented herein) for the expensed but unpaid part of the above reported compensation.

(2)

Option Grants in Last Fiscal Year

The Company did not issue any options during the nine months ended December 31, 2017.

Equity Compensation Plan Information

On April 12, 2011, subject to shareholder approval, the Board of Directors of Bravatek, Inc. (the “Company”) approved the adoption of the Bravatek, Inc. Stock Compensation Program (the “Program”) under which 540 shares have been reserved for purposes of possible future issuance of incentive stock options, non- qualified stock options, and restricted stock grants to employees, directors and certain key individuals. On April 15, 2011, pursuant to a written consent in lieu of a meeting, a majority of the Company's shareholders approved the Program. The purpose of the Program is to attract and retain key employees, consultants and other persons, and to provide such key individuals with an additional incentive to contribute to the success of the Company. In order to maintain flexibility in the award of stock benefits, the Program constitutes a single “omnibus” plan, but is composed of three parts. The first part is the Incentive Stock Option Plan (“Incentive Option Plan) which provides grants of incentive stock options under Section 422A of the Internal Revenue Code of 1986, as amended. The second part is the Nonqualified Stock Option Plan (“Nonqualified Option Plan”) which provides grants of nonqualified stock options. The third part is the Restricted Shares Plan (“Restricted Plan”) which provides grants of restricted shares of Company common stock. The Incentive Option Plan, the Nonqualified Option Plan and the Restricted Plan respectively comprise Plan I, Plan II, and Plan III of the Program. The foregoing description of the Program is qualified in its entirety by reference to the Bravatek, Inc. Stock Compensation Program which was filed as Exhibit 10.9 to Form 8-K filed with the Securities and Exchange Commission on April 20, 2011 and is hereby incorporated by reference.

The following table sets forth, as of June 30, 2018, the number of securities approved and available for future issuances under the Company's Stock Compensation Program.

Plan category	Number of securities to be issued upon exercise of outstanding options, warrants		Weighted average exercise price of outstanding options, warrants		Number of securities remaining available for future issuances under equity compensation plans

Equity compensation plans approved by security holders		102	$	1,102.94		-0-

Equity compensation plans not approved by security holders		-0-		-0-		-0-

Total		102	$	1,102.94		-0-

Table of Contents

Compensation Agreements

Dr. Thomas Cellucci’s Employment Agreement with the Company, as amended, includes compensation of $12,500 per month for his services as Chief Executive Officer and $1,500 in health insurance reimbursements. On March 27, 2015, Dr. Cellucci was granted a warrant to purchase 1,200 shares of the Company's common stock at a $750 per share exercise price, exercisable on a cashless basis, having a term of 5 years, and vesting immediately on March 27, 2015. As of December 31, 2017, the Company owed Dr. Cellucci $318,179 (included in accounts payable, related party on the December 31, 2017, balance sheet presented herein) for the expensed but unpaid part of the above reported salary.

Ms. King was named CFO of the Company on August 6, 2015. Pursuant to Ms. King’s consulting agreement, as amended, the Company currently compensates Ms. King for her services as CFO of the Company at $6,000 per month. On July 23, 2015, Ms. King was granted a warrant to purchase 30 shares of the Company's common stock at a $750 per share exercise price, exercisable on a cashless basis, having a term of 10 years, and vesting immediately on July 23, 2015.

Director Compensation

Our Board of Directors is comprised of Dr. Cellucci, Messrs. Brooks and Holmer and Ms. King. The compensation of Dr. Cellucci and Ms. King is disclosed in the Executive Compensation table, and Dr. Cellucci and Ms. King were not compensated separately for their services as directors. The following table provides summary information concerning compensation awarded to, earned by, or paid to our other directors for all services rendered to the Company for the nine months ended December 31, 2017.

Name and Principal Position	Fees Earned and Paid in Cash ($)		Stock Awarded ($)		Options Awarded ($)		Total ($)

Charles Brooks(1)		-0-		-0-		-0-		-0-
Hans Holmer (2)		-0-		-0-		-0-		-0-

_________

	(1)	Charles Brooks was appointed Director on March 16, 2015

	(2)	Hans Holmer was appointed Director on September 1, 2015.

Table of Contents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following tables set forth certain information regarding the beneficial ownership of our voting securities (Common Stock, Series C Preferred Stock and Series E Preferred Stock) as of September 30, 2018, of (i) each person known to us to beneficially own more than 5% of our stock, (ii) our directors, (iii) each named executive officer, and (iv) all directors and named executive officers as a group. As of September 30, 2018, there were a total of 9,982,694,590 shares of Common Stock issued and outstanding, 319,768 shares of Series C Preferred Stock issued and outstanding, and 1 share of Series E preferred stock issued and outstanding

The number of shares beneficially owned is determined under the rules promulgated by the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under those rules, beneficial ownership includes any shares as to which a person or entity has sole or shared voting power or investment power plus any shares which such person or entity has the right to acquire within sixty (60) days of September 30, 2018, through the exercise or conversion of any stock option, convertible security, warrant or other right. Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power (or shares such power with that person's spouse) with respect to all shares of capital stock listed as owned by that person or entity, and the address of each of the stockholders listed below is: c/o Bravatek Solutions, Inc. 2028 E. Ben White Blvd, Suite 240-2835, Austin, Texas 78741.

Title of Class	Name and Address	Number of Shares Beneficially Owned			Percent of Class (1)

Common Stock	Dr. Thomas A. Cellucci, CEO & Director		895	(2)		*	%

Common Stock	Debbie King, CFO & Director		30	(3)		*	%

Common Stock	Chuck Brooks, Director		30	(3)		*	%

Common Stock	Hans Holmer, Director		30	(3)		*	%

Common Stock	All Directors and Officers as a Group		985			*	%

Series C Preferred Stock	Dr. Thomas A. Cellucci, CEO & Director		223,768			70	%

Series C Preferred Stock	All Directors and Officers as a Group		223,768			70	%

Series E Preferred Stock	Dr. Thomas A. Cellucci, CEO & Director		1	(2)		100	%

Series E Preferred Stock	All Directors and Officers as a Group		1	(2)		100	%

________
*Lessthan0.01%

(1)	Applicable percentages of ownership are based on 9,982,694,590 shares of our Common Stock, 319,768 shares of Series C Preferred Stock issued and outstanding and 1 share of Series E Preferred Stock as of September 30, 2018. Beneficial ownership is determined in accordance with rules of the Securities and Exchange Commission and means voting or investment power with respect to securities. Shares of our Common Stock issuable upon the exercise of stock options exercisable, or convertible securities convertible, currently or within 60 days of September 30, 2018, are deemed outstanding and to be beneficially owned by the person holding such option for purposes of computing such person's percentage ownership, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.

(2)	Dr. Cellucci owns -0- shares of Common Stock, however, his Series C Preferred Stock is convertible into 895 shares of Common Stock. Each share of Series C Preferred stock entitles the holder thereof to 10,000 votes on all matters submitted to a vote of the stockholders of the Company. Dr. Cellucci has pledged his Series C Preferred Stock as collateral for certain of the issued convertible notes of the Company. The Series E Preferred Stock entitles its holder to a number of votes per share equal to twice the number of votes of all outstanding shares of capital stock of the Company.

(3)	Includes 30 shares of Common Stock issuable pursuant to vested stock options.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

Related Transactions

Effective December 21, 2017, the Company entered into a Joint Venture Agreement (the “Agreement”) with DarkPulse Technologies, Inc. (“DPTI”), pursuant to which (1) the parties formed a joint venture limited liability company in Delaware to develop, market and sell products and services based on DPTI’s patented BOTDA dark-pulse technology (the “Technology”) to be owned 40% by the Company and 60% by DPTI (the “JV”); (2) the Company funded $10,000 in initial capital to the JV; and (3) and the JV shall have an irrevocable royalty-free non-exclusive license to use the Technology in the North America, Asia and European government, military and CI/KR (Critical Infrastructure / Key Resources) market segments. While DPTI has a controlling financial interest in the JV, the Company and DPTI jointly manage the JV and any significant decisions and/or actions of the JV require the mutual consent of both parties. On January 25, 2018, our CEO was appointed to the Board of Directors of DPTI and on February 5, 2018, was named Co-CEO of DPTI. Additionally, during the six months ended June 30, 2018, the Company funded $87,000 to the JV and is the only party with a financial risk in the JV. Therefore, the Company is consolidating the JV in the condensed consolidated financial statements presented herein.

On June 2, 2015, the Company completed an acquisition of some of the assets and assumed certain liabilities of Viking Telecom Services, LLC (“Viking Telecom”) from Dependable Critical Infrastructure, Inc. (“DCI”), f/k/a DTREDS Consolidated, Inc. To acquire the assets, the Company issued 2,265 shares of common stock, 224 shares of common stock to be issued (valued in the aggregate at $740,000), paid $200,000 cash and forgave $59,204 of a note receivable from DCI. The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. The Company’s Chief Executive Officer owned approximately 30% of DCI. The Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016.

Table of Contents

The Company issued multiple unsecured notes payable from June 27, 2015 to March 31, 2017, to the Company’s CEO, for amounts received by the Company, or paid by the CEO, on behalf of the Company, totaling $188,362 (of which $31,850 was during the year ended March 31, 2017). The advances carry interest at 10% per annum and are due on demand. The Company recorded related party interest expense of $11,603 for the year ended March 31, 2017. During the year ended March 31, 2017, the Company made repayments of $12,224 of principal. As of March 31, 2017, the principal balance was $136,850 and the accrued and unpaid interest was $23,153. During the nine months ended December 31, 2017, the CEO advanced the Company $17,801 and the Company made repayments of $154,651 of principal and $31,118 of unpaid interest. As of December 31, 2017, there are no amounts due the CEO for any prior advances. For the nine months ended December 31, 2017, the Company recorded related party interest expense of $7,965.

There were no other material transactions, or series of similar transactions, during our Company's last fiscal year, or any currently proposed transactions, or series of similar transactions, to which our Company was or is to be a party, in which the amount involved exceeded the lesser of $120,000 or one percent of the average of the small business issuer's total assets at year-end for the last three completed fiscal years and in which any director, executive officer or any security holder who is known to us to own of record or beneficially more than five percent of any class of our common stock, or any member of the immediate family of any of the foregoing persons, had an interest.

Director Independence

The NASDAQ Stock Market has instituted director independence guidelines that have been adopted by the Securities & Exchange Commission. These guidelines provide that a director is deemed “independent” only if the board of directors affirmatively determines that the director has no relationship with the company which, in the board's opinion, would interfere with the director's exercise of independent judgment in carrying out his or her responsibilities. Significant stock ownership will not, by itself, preclude a board finding of independence.

For NASDAQ Stock Market listed companies, the director independence rules list six types of disqualifying relationships that preclude an independence filing. The Company's board of directors may not find independent a director who:

1.	is an employee of the company or any parent or subsidiary of the company;

2.	accepts, or who has a family member who accepts, more than $60,000 per year in payments from the company or any parent or subsidiary of the company other than (a) payments from board or committee services; (b) payments arising solely from investments in the company's securities; (c) compensation paid to a family member who is a non-executive employee of the company (d) benefits under a tax qualified retirement plan or non-discretionary compensation; or (e) loans to directors and executive officers permitted under Section 13(k) of the Exchange Act;

3.	is a family member of an individual who is employed as an executive officer by the company or any parent or subsidiary of the company;

4.	is, or has a family member who is, a partner in, or a controlling shareholder or an executive officer of, any organization to which the company made, or from which the company received, payments for property or services that exceed 5% of the recipient's consolidated gross revenues for that year, or $200,000, whichever is more, other than (a) payments arising solely from investments in the company's securities or (b) payments under non-discretionary charitable contribution matching programs; and

5.	is employed, or who has a family member who is employed, as an executive officer of another company whose compensation committee includes any executive officer of the listed company; or is, or has a family member who is, a current partner of the company's outside auditor, or was a partner or employee of the company's outside auditor who worked on the company's audit.

Based upon the foregoing criteria, our Board of Directors has determined that Dr. Cellucci (Chief Executive Officer and President) and Ms. King (Chief Financial Officer) are not independent directors under these rules.

Table of Contents

Bravatek Solutions, Inc.

PROSPECTUS

YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS DOCUMENT OR THAT WE HAVE REFERRED YOU TO. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT. THIS PROSPECTUS IS NOT AN OFFER TO SELL COMMON STOCK AND IS NOT SOLICITING AN OFFER TO BUY COMMON STOCK IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.

Until _____________, all dealers that effect transactions in these securities whether or not participating in this offering may be required to deliver a prospectus. This is in addition to the dealer’s obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

The Date of This Prospectus is _____

Table of Contents

BRAVATEK SOLUTIONS, INC.

INDEX

FINANCIAL STATEMENTS

UN AUDITED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 AND 2017

		Page
Balance Sheets		F-2
Statements of Operations		F-3
Statements of Cash Flows		F-4
Notes to Financial Statements		F-6

AUDITED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED DECEMBER 31, 2017 AND THE YEAR ENDED MARCH 31, 2017

		Page
Report of Independent Registered Public Accounting Firm		F-28
Balance Sheets		F-29
Statements of Operations		F-30
Statement of Stockholders' Deficit		F-31
Statements of Cash Flows		F-32
Notes to Financial Statements		F-33

F-1

BRAVATEK SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)


	June 30,			December 31,
	2018			2017
ASSETS
CURRENT ASSETS
Cash	$	65,485		$	189,357
Accounts receivable		298,046			24,897
Accounts receivable, related party		25,837			-
Prepaid expenses		111,019			23,080
Other assets		295,409			25,000
Investment in unconsolidated investee		25,000			-
TOTAL CURRENT ASSETS		820,896			262,334

Property and equipment, net		210,962			21,634
Intangible assets, net		1,770,842			133,929
Goodwill		1,339,259			-
TOTAL ASSETS	$	4,141,959		$	417,897

LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Convertible notes payable, net of discounts	$	1,004,895		$	797,797
Notes payable, current portion		904,652			830,788
Revolving line of credit		499,035			-
Bank term loans, current portion		97,139			-
Accounts payable and accrued liabilities		633,312			64,023
Accounts payable, related party		308,562			318,179
Accrued interest		367,543			335,258
Capital leases payable, current portion		12,045			-
Derivative liabilities		2,291,409			5,331,567
Deferred revenue		5,482			-
TOTAL CURRENT LIABILITIES		6,124,074			7,677,612

LONG- TERM LIABILITIES:
Notes payable, net of current portion		82,268			-
Capital leases payable, net of current portion		449			-
Bank term loans, net of current portion		180,491			-
Series D convertible preferred stock, 100,000 shares authorized and issued and outstanding		2,400,000			-
TOTAL LONG-TERM LIABILITIES		2,663,208			-

COMMITMENTS AND CONTINGENT LIABILITIES

STOCKHOLDERS' DEFICIT
Series A convertible preferred stock (5,000,000 shares authorized; par value $0.0001, -0- shares issued and outstanding at June 30, 2018, and December 31, 2017)		-			-
Series B preferred stock (350,000 shares authorized; par value $0.0001, 264,503 shares issued and outstanding at June 30, 2018, and December 31, 2017)		26			26
Series C preferred stock (1,000,000 shares authorized; par value $0.0001, 319,768 shares issued and outstanding at June 30, 2018, and December 31, 2017)		32			32
Series E preferred stock (1 share authorized; par value $0.0001, 1 share issued and outstanding at June 30, 2018)		-			-
Common stock (10,000,000,000 shares authorized; no par value; 9,266,957,705 and 8,040,670,036 shares issued and outstanding at June 30, 2018, and December 31, 2017, respectively)		6,431,060			5,385,977
Common stock to be issued (1,221 shares issuable at June 30, 2018, and December 31, 2017)		66,917			66,917
Additional paid in capital		21,053,191			17,370,682
Accumulated deficit		(32,196,133	)		(30,083,349	)
TOTAL STOCKHOLDERS' DEFICIT		(4,644,907	)		(7,259,715	)
Noncontrolling interest		416			-
TOTAL EQUITY		(4,645,323	)		(7,259,715	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	4,141,959		$	417,897

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

F-2

Table of Contents

BRAVATEK SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2018			2017			2018			2017
REVENUES
Sales, other	$	774,204		$	-		$	1,818,360		$	-
Sales, related party		-			-			24,837			-
Total revenues		774,204			-			1,843,197			-
Cost of services		627,439			-			1,448,531			1,083
GROSS PROFIT (LOSS)		146,765			-			394,666			(1,083	)

OPERATING EXPENSES
Management fees and expenses, related parties		2,489,424			57,000			2,625,905			113,500
Wages and employee expenses		15,799			-			90,275			-
Advertising and promotion		700			3,600			700			3,600
Rent, related party		34,500			-			65,714			-
General and administrative		168,999			27,636			349,845			38,955
Research and development		6,750			2,250			16,750			4,500
Professional fees		76,711			60,634			135,576			54,834
Amortization and depreciation		109,899			20,689			307,105			27,977
TOTAL OPERATING EXPENSES		2,902,782			171,809			3,591,870			243,366

OPERATING LOSS		(2,756,017	)		(171,809	)		(3,197,204	)		(244,449	)

OTHER INCOME (EXPENSES)
Interest expense		(652,541	)		(367,730	)		(1,515,176	)		(488,899	)
Interest expense related party		-			(2,915	)		-			(6,206	)
Other income		1,500			-			12,948			-
Gain (loss) on fair value of derivatives		831,894			(7,902,778	)		2,609,253			(7,443,912	)
Loss on extinguishment of debt		(3,021	)		-			(23,021	)		-
TOTAL OTHER INCOME (EXPENSES), NET		177,832			(8,273,423	)		1,084,004			(7,939,017	)

NET LOSS		(2,578,186	)		(8,445,232	)		(2,113,200	)		(8,183,466	)
Less: net loss attributable to noncontrolling interest		(416	)		-			(416	)		-
Net loss attributable to Bravatek Solutions, Inc.	$	(2,577,770	)	$	(8,445,232	)	$	(2,212,784	)	$	(8,183,466	)
LOSS PER SHARE

Basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE SHARES OUTSTANDING
Basic and diluted		8,849,020,450			4,790,615,050			8,694,453,203			3,376,199,318

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

F-3

Table of Contents

BRAVATEK SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

	FOR THE SIX MONTHS ENDED JUNE 30,
	2018			2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss attributable to Bravatek Solutions, Inc	$	(2,112,784	)	$	(8,183,466	)
Net loss attributable to noncontrolling interest		(416	)		-
Adjustments to reconcile net loss to net cash used in operations:
Amortization and depreciation		307,105			27,977
Non-cash interest and fees		-			72,504
Voting control value of preferred stock issued		2,333,140			-
Amortization of debt discounts		1,397,325			201,239
Loss (gain) on fair value of derivatives		(2,609,253	)		7,443,912
Changes in operating assets and liabilities:
Accounts receivable		112,815			-
Accounts receivable, related party		(24,837	)		-
Prepaid expenses and other receivables		(91,722	)		-
Accounts payable and accrued liabilities		(116,892	)		85,825
Accounts payable and accrued liabilities, related party		(4,171	)		52,040
Deferred revenue		5,482			-
NET CASH USED IN OPERATING ACTIVITIES		(804,208	)		(299,969	)

CASH FLOWS FROM INVESTING ACTIVITIES
Property and equipment		(10,190	)		-
Cash acquired in HelpComm acquisition		46,910			-
Purchase of note receivable		(25,000	)		-
Purchase of exclusive rights		(30,380	)		(200,000	)
NET CASH USED IN INVESTING ACTIVITIES		(18,660	)		(200,000	)

CASH FLOWS PROVIDED BY FINANCING ACTIVITIES
Payments of principal on notes and leases payable		(33,975	)		(323,162	)
Payments of principal on convertible notes payable		(62,461	)		(32,720	)
Proceeds from issuance of convertible debt, net		757,000			948,250
Proceeds from loan-related party		-			11,301
Repayments of loan-related party		-			(38,151	)
Payments of principal on bank term notes payable		(45,114	)		-
Proceeds from revolving line of credit		626,600			-
Payments of revolving line of credit		(543,054	)		-
NET CASH PROVIDED BY FINANCING ACTIVITIES		698,996			565,518

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(123,872	)		65,549

CASH AND CASH EQUIVALENTS
Beginning of period		189,357			257
End of period	$	65,485		$	65,806

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	$	63,446		$	149,315
Cash paid for income taxes	$	-		$	-


SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued in settlement of debt and interest on convertible debt	$	1,045,083		$	731,965
Shares to be issued in settlement of debt and interest on convertible debt	$	-		$	6,521
Original issue discounts	$	65,525		$	72,075
Original debt discount against derivative liabilities	$	900,965		$	1,131,859
Initial value of derivative liabilities	$	1,271,999		$	3,308,630
Reclassification of derivatives upon conversion of convertible debt	$	1,324,370		$	5,298,808
Issuances of notes payable for property and equipment	$	46,000		$	-
Series E Preferred Stock issued for debt forgiveness, related party	$	25,000		$	-

Acquisition of HelpComm, Inc.
Issuance of Series D Preferred stock as consideration	$	2,400,000		$	-
Assumed liabilities		1,711,389			-
Accounts receivable		(386,964	)		-
Property and equipment		(171,714	)		-
Other Assets		(292,994	)		-
Intangible assets		(3,212,807	)		-
Cash acquired	$	46,910		$	-

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

F-4